Guaranty Bancshares (GNTY) 10-Q 20 Jun 17 2017 Q1 Quarterly report Financial data

DOCUMENT AND ENTITY INFORMATION

DOCUMENT AND ENTITY INFORMATION - shares	3 Months Ended
	Mar. 31, 2017	Jun. 20, 2017
Document And Entity Information [Abstract]
Entity Registrant Name	GUARANTY BANCSHARES INC /TX/
Entity Central Index Key	1,058,867
Document Type	10-Q
Document Period End Date	Mar. 31, 2017
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Entity Current Reporting Status	No
Entity Filer Category	Non-accelerated Filer
Document Fiscal Year Focus	2,017
Document Fiscal Period Focus	Q1
Entity Common Stock, Shares Outstanding		11,053,933

CONSOLIDATED BALANCE SHEETS

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Mar. 31, 2017	Dec. 31, 2016
ASSETS
Cash and due from banks	$ 32,576	$ 39,605
Federal funds sold	83,175	60,600
Interest-bearing deposits	28,006	27,338
Total cash and cash equivalents	143,757	127,543
Securities available for sale	214,463	156,925
Securities held to maturity	185,837	189,371
Loans held for sale	1,446	2,563
Loans, net	1,241,215	1,233,651
Accrued interest receivable	6,304	7,419
Premises and equipment, net	44,823	44,810
Other real estate owned	1,637	1,692
Cash surrender value of life insurance	17,922	17,804
Deferred tax asset	4,426	4,892
Core deposit intangible, net	3,162	3,308
Goodwill	18,742	18,742
Other assets	17,465	19,616
Total assets	1,901,199	1,828,336
Deposits:
Noninterest-bearing	370,810	358,752
Interest-bearing	1,300,361	1,218,039
Total deposits	1,671,171	1,576,791
Securities sold under agreements to repurchase	12,663	10,859
Accrued interest and other liabilities	7,595	6,006
Other debt	18,929	18,286
Federal Home Loan Bank advances	25,165	55,170
Subordinated debentures	19,310	19,310
Total liabilities	1,754,833	1,686,422
Commitments and contingent liabilities
KSOP-owned shares	34,300	31,661
Shareholders' equity
Preferred stock, $5.00 par value, 15,000,000 shares authorized, no shares issued	0	0
Common stock, $1.00 par value, 50,000,000 shares authorized, 9,616,275 issued, 8,753,933 and 8,751,923 shares outstanding, respectively	9,616	9,616
Additional paid-in capital	101,796	101,736
Retained earnings	60,676	57,160
Treasury stock, 862,342 and 864,352 shares at cost	(20,087)	(20,111)
Accumulated other comprehensive loss	(5,635)	(6,487)
Stockholder's equity, including KSOP-owned shares	146,366	141,914
Less KSOP-owned shares	34,300	31,661
Total shareholders' equity	112,066	110,253
Liabilities and shareholders' equity	1,901,199	$ 1,828,336
Pro Forma
ASSETS
Cash and due from banks	32,576
Federal funds sold	83,175
Interest-bearing deposits	28,006
Total cash and cash equivalents	143,757
Securities available for sale	214,463
Securities held to maturity	185,837
Loans held for sale	1,446
Loans, net	1,241,215
Accrued interest receivable	6,304
Premises and equipment, net	44,823
Other real estate owned	1,637
Cash surrender value of life insurance	17,922
Deferred tax asset	4,426
Core deposit intangible, net	3,162
Goodwill	18,742
Other assets	17,465
Total assets	1,901,199
Deposits:
Noninterest-bearing	370,810
Interest-bearing	1,300,361
Total deposits	1,671,171
Securities sold under agreements to repurchase	12,663
Accrued interest and other liabilities	7,595
Other debt	18,929
Federal Home Loan Bank advances	25,165
Subordinated debentures	19,310
Total liabilities	1,754,833
Commitments and contingent liabilities
KSOP-owned shares	0
Shareholders' equity
Preferred stock, $5.00 par value, 15,000,000 shares authorized, no shares issued	0
Common stock, $1.00 par value, 50,000,000 shares authorized, 9,616,275 issued, 8,753,933 and 8,751,923 shares outstanding, respectively	9,616
Additional paid-in capital	101,796
Retained earnings	60,676
Treasury stock, 862,342 and 864,352 shares at cost	(20,087)
Accumulated other comprehensive loss	(5,635)
Stockholder's equity, including KSOP-owned shares	146,366
Less KSOP-owned shares	0
Total shareholders' equity	146,366
Liabilities and shareholders' equity	$ 1,901,199

CONSOLIDATED BALANCE SHEETS (Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares	Mar. 31, 2017	Dec. 31, 2016
Statement of Financial Position [Abstract]
Preferred stock, par value (in USD per share)	$ 5	$ 5
Preferred stock, shares authorized (in shares)	15,000,000	15,000,000
Preferred stock, shares issued (in shares)	0	0
Common stock, par value (in USD per share)	$ 1	$ 1
Common stock, shares authorized (in shares)	50,000,000	50,000,000
Common stock, shares issued (in shares)	9,616,275	9,616,275
Common stock, shares outstanding (in shares)	8,753,933	8,751,923
Treasury stock (in shares)	862,342	864,352

CONSOLIDATED STATEMENTS OF EARN

CONSOLIDATED STATEMENTS OF EARNINGS (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Interest income
Loans, including fees	$ 14,415	$ 12,914
Securities
Taxable	1,311	1,867
Nontaxable	922	515
Federal funds sold and interest-bearing deposits	488	173
Total interest income	17,136	15,469
Interest expense
Deposits	2,404	2,186
FHLB advances and federal funds purchased	79	64
Subordinated debentures	207	222
Other borrowed money	205	194
Total interest expense	2,895	2,666
Net interest income	14,241	12,803
Provision for loan losses	650	450
Net interest income after provision for loan losses	13,591	12,353
Noninterest income
Service charges	877	823
Net realized gain on securities transactions	0	37
Net realized gain on sale of loans	429	226
Other operating income	1,976	1,805
Total noninterest income	3,282	2,891
Noninterest expense
Employee compensation and benefits	6,987	6,450
Occupancy expenses	1,748	1,747
Other operating expenses	3,310	3,280
Total noninterest expense	12,045	11,477
Income before income taxes	4,828	3,767
Income tax provision	1,312	1,090
Net earnings	$ 3,516	$ 2,677
Basic earnings per share (in USD per share)	$ 0.40	$ 0.30
Diluted earnings per share (in USD per share)	$ 0.40	$ 0.30

CONSOLIDATED STATEMENTS OF COMP

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Statement of Comprehensive Income [Abstract]
Net earnings	$ 3,516	$ 2,677
Unrealized gains on securities
Unrealized holding gains arising during the period	1,229	2,492
Amortization of net unrealized gains on held to maturity securities	18	25
Reclassification adjustment for net gains included in net earnings	0	(37)
Tax effect	(430)	(859)
Unrealized gains on securities, net of tax	817	1,621
Unrealized holding gains (losses) arising during the period on interest rate swaps	35	(225)
Total other comprehensive income	852	1,396
Comprehensive income	$ 4,368	$ 4,073

CONSOLIDATED STATEMENTS OF CHAN

CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (Unaudited) - USD ($) $ in Thousands	Total	Preferred Stock	Common Stock	Additional Paid-in Capital	Retained Earnings	Treasury Stock	Accumulated Other Comprehensive Loss	Less: KSOP-Owned Shares
Beginning balance at Dec. 31, 2015	$ 102,352	$ 0	$ 9,616	$ 101,525	$ 49,654	$ (16,486)	$ (6,573)	$ (35,384)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings	2,677				2,677
Other comprehensive income	1,396						1,396
Purchase of treasury stock	(3,000)							(3,000)
Sale of treasury stock	8,557					8,557
Stock based compensation	39			39
Net change in fair value of KSOP shares	(1,538)							(1,538)
Ending balance at Mar. 31, 2016	110,483	0	9,616	101,564	52,331	(7,929)	(5,177)	(39,922)
Beginning balance at Dec. 31, 2016	110,253	0	9,616	101,736	57,160	(20,111)	(6,487)	(31,661)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings	3,516				3,516
Other comprehensive income	852						852
Exercise of stock options	24					24
Stock based compensation	60			60
Net change in fair value of KSOP shares	(2,639)							(2,639)
Ending balance at Mar. 31, 2017	$ 112,066	$ 0	$ 9,616	$ 101,796	$ 60,676	$ (20,087)	$ (5,635)	$ (34,300)

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in Thousands	3 Months Ended		12 Months Ended
	Mar. 31, 2017	Mar. 31, 2016	Dec. 31, 2016
Cash flows from operating activities
Net earnings	$ 3,516	$ 2,677
Adjustments to reconcile net earnings to net cash provided from operating activities:
Depreciation	801	777
Amortization	264	241
Deferred taxes	2,402	(496)
Premium amortization, net of discount accretion	1,113	1,172
Net realized gain on securities transactions	0	(37)
Gain on loans held for sale	(429)	(226)
Provision for loan losses	650	450	$ 3,640
Origination of loans held for sale	(13,232)	(13,726)
Proceeds from loans held for sale	14,778	12,835
Net loss on sale of premises, equipment, other real estate owned and other assets	27	(8)
Stock based compensation	60	39
Net change in accrued interest receivable and other assets	2,265	(1,286)
Net change in accrued interest payable and other liabilities	21	334
Net cash provided by operating activities	12,236	2,746
Securities available for sale:
Purchases	(61,965)	(18,252)
Proceeds from sales	0	21,754
Proceeds from maturities and principal repayments	5,203	38,444
Securities held to maturity:
Purchases	0	(79,649)
Proceeds from sales	0	1,866
Proceeds from maturities and principal repayments	2,892	3,419
Net purchases of premises and equipment	(814)	(474)
Net proceeds from sale of premises, equipment, other real estate owned and other assets	191	353
Net increase in loans	(8,375)	(73,629)
Net cash used in investing activities	(62,868)	(106,168)
Cash flows from financing activities
Net change in deposits	94,380	56,521
Net change in securities sold under agreements to repurchase	1,804	(2,904)
Proceeds from FHLB advances	0	50,000
Repayment of FHLB advances	(30,005)	(5,051)
Proceeds from other debt	1,000	0
Repayment of other debt	(357)	0
Sale of treasury stock	0	8,557
Exercise of stock options	24	0
Net cash provided by financing activities	66,846	107,123
Net change in cash and cash equivalents	16,214	3,701
Cash and cash equivalents at beginning of year	127,543	111,379	111,379
Cash and cash equivalents at end of period	143,757	115,080	$ 127,543
Supplemental disclosures of cash flow information
Interest paid	2,774	2,587
Income taxes paid	0	1,300
Supplemental schedule of noncash investing and financing activities
Transfer loans to other real estate owned and repossessed assets	161	185
Net change in fair value of KSOP shares	$ 2,639	$ 1,538

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	3 Months Ended
	Mar. 31, 2017
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Nature of Operations : Guaranty Bancshares, Inc. (“Guaranty”) is a bank holding company headquartered in Mount Pleasant, Texas that provides, through its wholly-owned subsidiary, Guaranty Bank & Trust, N.A. (the “Bank”), a broad array of financial products and services to individuals and corporate customers, primarily in its markets of East Texas, Bryan/College Station and the Dallas/Fort Worth metroplex. The terms “the Company,” “we,” “us” and “our” mean Guaranty and its subsidiaries, when appropriate. The Company’s main sources of income are derived from granting loans throughout its markets and investing in securities issued by the U.S. Treasury, U.S. government agencies and state and political subdivisions. The Company’s primary lending products are real estate, commercial and consumer loans. Although the Company has a diversified loan portfolio, a substantial portion of its debtors’ abilities to honor contracts is dependent on the economy of the State of Texas and primarily the economies of East Texas, Bryan/College Station and the Dallas/Fort Worth metroplex. The Company primarily funds its lending activities with deposit operations. The Company’s primary deposit products are checking accounts, money market accounts and certificates of deposit. Basis of Presentation : The consolidated financial statements in this Quarterly Report on Form 10-Q (this “Report”) include the accounts of Guaranty, the Bank, and their respective other direct and indirect subsidiaries and any other entities in which Guaranty has a controlling interest. The Bank has five wholly-owned non-bank subsidiaries, Guaranty Company, Inc., G B COM, INC., 2800 South Texas Avenue LLC, Pin Oak Realty Holdings, Inc. and Pin Oak Energy Holdings, LLC. All significant intercompany balances and transactions have been eliminated in consolidation. The accounting and financial reporting policies we follow conform, in all material respects, to accounting principles generally accepted in the United States of America (“GAAP”) and to general practices within the financial services industry. The consolidated financial statements in this Report have not been audited by an independent registered public accounting firm, but in the opinion of management, reflect all adjustments necessary for a fair presentation of our financial position and results of operations. All such adjustments were of a normal and recurring nature. The consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States for interim financial information and with the instructions to Form 10-Q adopted by the Securities and Exchange Commission (“SEC”). Accordingly, the financial statements do not include all of the information and footnotes required by GAAP for complete financial statements and should be read in conjunction with our consolidated financial statements, and notes thereto, for the year ended December 31, 2016 , included in our Prospectus filed with the SEC under Rule 424(b) on May 9, 2017, relating to our initial public offering. Operating results for the interim periods disclosed herein are not necessarily indicative of the results that may be expected for a full year or any future period. All dollar amounts referenced and discussed in the notes to the consolidated financial statements in this Report are presented in thousands, unless noted otherwise. The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. These estimates and assumptions may also affect disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates. Unaudited Pro Forma Financial Information - KSOP Repurchase Right : In accordance with applicable provisions of the Internal Revenue Code, the terms of our employee stock ownership plan with 401(k) provisions (“KSOP”), provided that, for so long as we were a privately-held company, KSOP participants would have the right, for a specified period of time, to require us to repurchase shares of our common stock that are distributed to them by the KSOP. This repurchase obligation terminated upon the consummation of our initial public offering and listing of our common stock on the NASDAQ Global Select Market in May 2017. However, because we were privately-held during the periods covered by the Report, the shares of common stock held by the KSOP are reflected in our consolidated balance sheet as a line item called “KSOP-owned shares,” appearing between total liabilities and shareholders’ equity. As a result, the KSOP-owned shares are deducted from shareholders’ equity in our consolidated balance sheet for the periods included in this Report. The consolidated balance sheet in this Report includes a pro forma column, which assumes that the KSOP repurchase obligation has terminated as of the date presented in the Report. For all periods following our initial public offering and continued listing of our common stock on the NASDAQ Global Select Market, the KSOP-owned shares will be included in, and not be deducted from, shareholders’ equity. Subsequent Events : During May 2017 , the Company completed an initial public offering issuing 2,300,000 shares of common stock, par value $1.00 per share, at a purchase price of $27.00 per share, representing gross proceeds of $62,100 . Net proceeds after underwriting discounts and expenses were approximately $57,600 . The Company used a portion of the proceeds to repay in full the outstanding balance on our unsecured line of credit with a correspondent bank of $19,900 and repay $5,000 of the subordinated debentures. In addition, the Company contributed $15,000 of the proceeds to the Bank. The Company has retained the remaining proceeds of the offering for general corporate purposes. Recent Accounting Pronouncements: In January 2017, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update (“ASU”) 2017-01, Business Combinations (Topic 805): Clarifying the Definition of a Business . The ASU is intended to clarify the definition of a business with the objective of adding guidance to assist entities with evaluating whether transactions should be accounted for as acquisitions (or disposals) of assets or businesses. In addition, the amendments in this update provide a detailed framework to assist entities in evaluating whether a set of assets and activities constitutes a business, as well as clarify the definition of the term output so the term is consistent with how outputs are described in Topic 606. ASU 2017-01 is effective for public companies for annual periods beginning after December 15, 2017, including interim periods within those periods. In January 2017, the FASB issued ASU 2017-04, Intangibles - Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment . This ASU simplifies the accounting for goodwill impairment for all entities by requiring impairment changes to be based on the first step in today’s two-step impairment test, thus eliminating step two from the goodwill impairment test. In addition, the amendment eliminates the requirements for any reporting unit with a zero or negative carrying amount to perform a qualitative assessment and, if it fails that qualitative test, to perform step two of the goodwill impairment test. For pubic companies, ASU 2017-04 is effective for fiscal years beginning after December 15, 2019 with early adoption permitted for interim or annual goodwill impairment tests performed on testing dates after January 1, 2017. The Company is in process of evaluating the impact of this pronouncement, which is not expected to have a significant impact on the consolidated financial statements. In November 2016, the FASB issued ASU 2016-18, Statement of Cash Flows (Topic 230): Restricted Cash , which requires that the statement of cash flows explain the change during the period in the total of cash, cash equivalents, and amounts generally described as restricted cash or restricted cash equivalents. For public companies, ASU 2016-18 is effective for fiscal years beginning after December 15, 2017, and interim periods within those fiscal years. Early adoption is permitted. The Company is in process of evaluating the impact of this pronouncement, which is not expected to have a significant impact on the consolidated financial statements. In August 2016, the FASB issued ASU 2016-15, Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments , to address diversity in how certain cash receipts and cash payments are presented and classified in the statement of cash flows. The amendments provide guidance on the following nine specific cash flow issues: 1) debt prepayment or debt extinguishment costs; 2) settlement of zero-coupon debt instruments or other debt instruments with coupon interest rates that are insignificant in relation to the effective interest rate of the borrowing; 3) contingent consideration payments made after a business combination; 4) proceeds from the settlement of insurance claims; 5) proceeds from the settlement of corporate-owned life insurance policies, including bank-owned; 6) life insurance policies; 7) distributions received from equity method investees; 8) beneficial interests in securitization transactions; and 9) separately identifiable cash flows and application of the predominance principle. The amendments are effective for public companies for fiscal years beginning after December 31, 2017, and interim periods within those fiscal years. Early adoption is permitted, including adoption in an interim period. The Company does not expect the adoption of this guidance to be material to the consolidated financial statements. In June 2016, the FASB issued ASU 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments , which sets forth a "current expected credit loss" ("CECL") model requiring the Company to measure all expected credit losses for financial instruments held at the reporting date based on historical experience, current conditions and reasonable supportable forecasts. This replaces the existing incurred loss model and is applicable to the measurement of credit losses on financial assets measured at amortized cost and applies to some off-balance sheet credit exposures. For public companies, the amendments in this update are effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. The Company is currently in the process of assembling a transition team to assess the adoption of this ASU, which will develop a project plan regarding implementation. In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842) . The FASB issued this ASU to increase transparency and comparability among organizations by recognizing lease assets and lease liabilities on the balance sheet by lessees for those leases classified as operating leases under current U.S. GAAP and disclosing key information about leasing arrangements. The amendments in this ASU are effective for public companies for annual periods, and interim periods within those annual periods, beginning after December 15, 2018. Early application of this ASU is permitted for all entities. The Company is currently evaluating the impact of adopting the new guidance on its consolidated financial statements. In January 2016, the FASB issued ASU 2016-01, Financial Instruments - Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Liabilities , which is intended to improve the recognition and measurement of financial instruments by requiring: equity investments (other than equity method or consolidation) to be measured at fair value with changes in fair value recognized in net income; public business entities to use the exit price notion when measuring the fair value of financial instruments for disclosure purposes; separate presentation of financial assets and financial liabilities by measurement category and form of financial asset (i.e., securities or loans and receivables) on the balance sheet or the accompanying notes to the financial statements; eliminating the requirement to disclose the fair value of financial instruments measured at amortized cost for organizations that are not public business entities; eliminating the requirement for public business entities to disclose the method(s) and significant assumptions used to estimate the fair value that is required to be disclosed for financial instruments measured at amortized cost on the balance sheet; and requiring a reporting organization to present separately in other comprehensive income the portion of the total change in the fair value of a liability resulting from a change in the instrument-specific credit risk (also referred to as “own credit”) when the organization has elected to measure the liability at fair value in accordance with the fair value option for financial instruments. This ASU is effective for public companies for fiscal years beginning after December 15, 2017, including interim periods within those fiscal years. This ASU permits early adoption of the instrument-specific credit risk provision. The Company is currently evaluating the impact of adopting the new guidance on its consolidated financial statements. In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers (Topic 606), followed by various amendments : ASU 2015-14, Revenue from Contracts with Customers (Topic 606): Deferral of the Effective Date, ASU 2016-08, Revenue from Contracts with Customers (Topic 606): Principal versus Agent Considerations (Reporting Revenue Gross versus Net), ASU 2016-10, Revenue from Contracts with Customers (Topic 606): Identifying Performance Obligations and Licensing, ASU 2016-11, Revenue Recognition (Topic 605) and Derivatives and Hedging (Topic 815): Rescission of SEC Guidance Because of Accounting Standards Updates 2014-09 and 2014-16 Pursuant to Staff Announcements at the March 3, 2016 EITF Meeting, and ASU 2016-12, Revenue from Contracts with Customers (Topic 606): Narrow-Scope Improvements and Practical Expedients. The amendments in these updates amend existing guidance related to revenue from contracts with customers. The amendments supersede and replace nearly all existing revenue recognition guidance, including industry-specific guidance, establish a new control-based revenue recognition model, change the basis for deciding when revenue is recognized over a time or point in time, provide new and more detailed guidance on specific topics and expand and improve disclosures about revenue. In addition, these amendments specify the accounting for some costs to obtain or fulfill a contract with a customer. The amendments are effective for annual and interim periods beginning after December 15, 2017, and must be retrospectively applied. The majority of the Company's income consists of net interest income on financial assets and financial liabilities, which is explicitly excluded from the scope of the amendments. The Company continues to evaluate the impact of the amendments on the components of noninterest income that have recurring revenue streams; however, the Company does not expect any recognition changes to have a significant impact to the Company's consolidated financial statements.

ACQUISITIONS

ACQUISITIONS	3 Months Ended
	Mar. 31, 2017
Business Combinations [Abstract]
ACQUISITIONS	ACQUISITIONS On close of business August 6, 2016, the Company purchased certain assets and assumed certain liabilities associated with a former branch location of a non-related bank in Denton, Texas (Denton), which resulted in the addition of approximately $4,659 in assets and liabilities. The Company acquired the bank premises at 4101 Wind River Lane in Denton and recorded it at fair market value of $2,075 . Other assets acquired, at fair value, included cash of $2,399 , core deposit intangible of $42 , goodwill of $141 and loans of $2 . Liabilities assumed included non-interest bearing deposits of $581 , interest bearing deposits of $4,047 and other liabilities of $30 . Consideration paid by the Company for the acquired assets and assumed liabilities of $66 was netted against the cash received. Goodwill of $141 for Denton arising from the acquisition consisted largely of synergies and the cost savings resulting from the combining of the operations of the companies. Goodwill of $141 is expected to be deductible for income taxes purposes.

MARKETABLE SECURITIES

MARKETABLE SECURITIES	3 Months Ended
	Mar. 31, 2017
Investments, Debt and Equity Securities [Abstract]
MARKETABLE SECURITIES	MARKETABLE SECURITIES The following tables summarize the amortized cost and fair value of securities available for sale and securities held to maturity as of March 31, 2017 and December 31, 2016 and the corresponding amounts of gross unrealized gains and losses: March 31, 2017 Amortized Cost Gross Unrealized Gains Gross Estimated Fair Value Available for sale: Corporate bonds $ 25,223 $ 73 $ 123 $ 25,173 Municipal securities 7,817 — 539 7,278 Mortgage-backed securities 80,766 15 1,236 79,545 Collateralized mortgage obligations 102,688 236 457 102,467 Total available for sale $ 216,494 $ 324 $ 2,355 $ 214,463 Held to maturity: Municipal securities $ 148,520 $ 1,428 $ 2,621 $ 147,327 Mortgage-backed securities 26,900 312 191 27,021 Collateralized mortgage obligations 10,417 249 602 10,064 Total held to maturity $ 185,837 $ 1,989 $ 3,414 $ 184,412 December 31, 2016 Amortized Cost Gross Unrealized Gains Gross Estimated Fair Value Available for sale: Corporate bonds $ 25,254 $ 6 $ 377 $ 24,883 Municipal securities 7,841 — 622 7,219 Mortgage-backed securities 61,298 — 1,608 59,690 Collateralized mortgage obligations 65,789 10 666 65,133 Total available for sale $ 160,182 $ 16 $ 3,273 $ 156,925 Held to maturity: Municipal securities $ 149,420 $ 901 $ 3,889 $ 146,432 Mortgage-backed securities 28,450 318 290 28,478 Collateralized mortgage obligations 11,501 265 521 11,245 Total held to maturity $ 189,371 $ 1,484 $ 4,700 $ 186,155 The Company’s mortgage-backed securities portfolio includes non-agency collateralized mortgage obligations with a carrying value of $1,493 which had unrealized losses of $602 at March 31, 2017 . These non-agency mortgage-backed securities were rated AAA at purchase. The Company monitors to ensure it has adequate credit support and the Company records OTTI as appropriate. The Company does not have the intent to sell these securities and it is likely that it will not be required to sell the securities before their anticipated recovery. Management evaluates securities for OTTI on at least a quarterly basis, and more frequently when economic or market concerns warrant such evaluation. Consideration is given to (1) the length of time and the extent to which the fair value has been less than cost, (2) the financial condition and near-term prospects of the issuer, and (3) the intent and ability of the Company to retain its investment in the issuer for a period of time sufficient to allow for any anticipated recovery in fair value. There were no other than temporary impairment losses on debt securities related to credit losses recognized during the three months ended March 31, 2017 or for the year ended December 31, 2016 . Information pertaining to securities with gross unrealized losses as of March 31, 2017 and December 31, 2016 aggregated by investment category and length of time that individual securities have been in a continuous unrealized loss position is detailed in the following tables: Less Than 12 Months 12 Months or Longer Total March 31, 2017 Gross Unrealized Losses Estimated Fair Value Gross Unrealized Losses Estimated Fair Value Gross Unrealized Losses Estimated Fair Value Available for sale: Corporate bonds $ (123 ) $ 12,508 $ — $ — $ (123 ) $ 12,508 Municipal securities (539 ) 7,278 — — (539 ) 7,278 Mortgage-backed securities (761 ) 62,344 (475 ) 14,870 (1,236 ) 77,214 Collateralized mortgage obligations (272 ) 42,026 (185 ) 8,645 (457 ) 50,671 Total available for sale $ (1,695 ) $ 124,156 $ (660 ) $ 23,515 $ (2,355 ) $ 147,671 Held to maturity: Municipal securities $ (2,414 ) $ 84,716 $ (207 ) $ 5,965 $ (2,621 ) $ 90,681 Mortgage-backed securities (191 ) 18,024 — — (191 ) 18,024 Collateralized mortgage obligations — — (602 ) 2,237 (602 ) 2,237 Total held to maturity $ (2,605 ) $ 102,740 $ (809 ) $ 8,202 $ (3,414 ) $ 110,942 Less Than 12 Months 12 Months or Longer Total December 31, 2016 Gross Unrealized Losses Estimated Fair Value Gross Unrealized Losses Estimated Fair Value Gross Unrealized Losses Estimated Fair Value Available for sale: Corporate bonds $ (377 ) $ 22,529 $ — $ — $ (377 ) $ 22,529 Municipal securities (622 ) 7,219 — — (622 ) 7,219 Mortgage-backed securities (1,047 ) 44,420 (561 ) 15,270 (1,608 ) 59,690 Collateralized mortgage obligations (437 ) 55,435 (229 ) 9,049 (666 ) 64,484 Total available for sale $ (2,483 ) $ 129,603 $ (790 ) $ 24,319 $ (3,273 ) $ 153,922 Held to maturity: Municipal securities $ (3,889 ) $ 98,943 $ — $ — $ (3,889 ) $ 98,943 Mortgage-backed securities (290 ) 19,983 — — (290 ) 19,983 Collateralized mortgage obligations — — (521 ) 2,350 (521 ) 2,350 Total held to maturity $ (4,179 ) $ 118,926 $ (521 ) $ 2,350 $ (4,700 ) $ 121,276 The number of investment positions in an unrealized loss position totaled 152 and 177 at March 31, 2017 and December 31, 2016 , respectively. The securities in a loss position were composed of tax exempt municipal bonds, corporate bonds, collateralized mortgage obligations and mortgage backed securities. Management believes the unrealized loss on the remaining securities is a function of the movement of interest rates since the time of purchase. Based on evaluation of available evidence, including recent changes in interest rates, credit rating information and information obtained from regulatory filings, management believes the declines in fair value for these securities are temporary. Should the impairment of any of these securities become other-than-temporary, the cost basis of the investment would be reduced and the resulting loss recognized in net income in the period the other-than-temporary impairment is identified. The Company does not have the intent to sell these mortgage-backed securities and it is likely that it will not be required to sell the securities before their anticipated recovery. The Company does not consider these securities to be other-than-temporarily impaired at March 31, 2017 . Mortgage-backed securities and collateralized mortgage obligations are backed by pools of mortgages that are insured or guaranteed by the Federal Home Loan Mortgage Corporation (FHLMC), the Federal National Mortgage Association (FNMA) or the Government National Mortgage Association (GNMA). As of March 31, 2017 , there were no holdings of securities of any one issuer, other than the U.S. government and its agencies, in an amount greater than 10% of shareholders’ equity. Securities with fair values of approximately $264,248 and $259,499 at March 31, 2017 and December 31, 2016 , respectively, were pledged to secure public fund deposits and for other purposes as required or permitted by law. The proceeds from sales of securities and the associated gains and losses are listed below for: Three Months Ended March 31, 2017 2016 Proceeds $ — $ 23,620 Gross gains — 75 Gross losses — (38 ) During the three months ended March 31, 2016 , the Company sold three held to maturity securities. The Company sold these municipal securities based upon internal credit analysis, under the belief that they had experienced significant deterioration in creditworthiness. The risk exposure presented by these municipalities had increased beyond acceptable levels, and we determined that it was reasonably possible that all amounts due would not be collected. The credit analysis determined that the municipalities had been significantly impacted by the significant decline in market oil prices due to the fact that their tax bases are heavily reliant on the energy industry relative to other sectors of the economy. Specifically, the revenues of these municipalities had been adversely impacted by the sustained low-level of oil prices. The Company believes the sale of these securities were merited and permissible under the applicable accounting guidelines because of the significant deterioration in the creditworthiness of the issuers. Sale of securities held to maturity were as follows for: Three Months Ended March 31, 2017 2016 Proceeds from sales $ — $ 1,866 Amortized cost — 1,842 Gross realized gains — 24 Tax expense related to securities gains/losses — (7 ) The contractual maturities at March 31, 2017 of available for sale and held to maturity securities at carrying value and estimated fair value are shown below. The Company invests in mortgage-backed securities and collateralized mortgage obligations that have expected maturities that differ from their contractual maturities. These differences arise because borrowers and/or issuers may have the right to call or prepay their obligation with or without call or prepayment penalties. Available for Sale Held to Maturity Amortized Cost Estimated Fair Value Amortized Cost Estimated Fair Value Due within one year $ — $ — $ 1,050 $ 1,055 Due after one year through five years 7,444 7,478 5,577 5,722 Due after five years through ten years 17,779 17,695 40,910 41,560 Due after ten years 7,817 7,278 100,983 98,990 Mortgage-backed securities 80,766 79,545 26,900 27,021 Collateralized mortgage obligations 102,688 102,467 10,417 10,064 $ 216,494 $ 214,463 $ 185,837 $ 184,412

LOANS AND ALLOWANCE FOR LOAN LO

LOANS AND ALLOWANCE FOR LOAN LOSSES	3 Months Ended
	Mar. 31, 2017
Receivables [Abstract]
LOANS AND ALLOWANCE FOR LOAN LOSSES	LOANS AND ALLOWANCE FOR LOAN LOSSES The following table summarizes our loan portfolio by type of loan as of: March 31, 2017 December 31, 2016 Commercial and industrial $ 205,903 $ 223,997 Real estate: Construction and development 152,760 129,366 Commercial real estate 372,855 367,656 Farmland 62,130 62,362 1-4 family residential 360,873 362,952 Multi-family residential 23,943 26,079 Consumer 52,816 53,505 Agricultural 21,473 18,901 Overdrafts 390 317 Total loans 1,253,143 1,245,135 Less: Allowance for loan losses 11,928 11,484 Total net loans $ 1,241,215 $ 1,233,651 As of March 31, 2017 and December 31, 2016 , included in total loans above were $1,055 and $1,210 in unamortized loan costs, net of loan fees, respectively. The following table presents the activity in the allowance for loan losses and the recorded investment in loans by portfolio segment and based on impairment method for the three months ended March 31, 2017 , for the year ended December 31, 2016 and for the three months ended March 31, 2016 : For the three months ended March 31, 2017 Commercial Construction Commercial Farmland 1-4 family Multi-family Consumer Agricultural Overdrafts Total Allowance for loan losses: Beginning balance $ 1,592 $ 1,161 $ 3,264 $ 482 $ 3,960 $ 281 $ 585 $ 153 $ 6 $ 11,484 Provision for loan losses 177 188 123 (10 ) (72 ) (53 ) 280 2 15 650 Loans charged-off (6 ) — — — (118 ) — (89 ) — (35 ) (248 ) Recoveries — — — — — — 22 — 20 42 Ending balance $ 1,763 $ 1,349 $ 3,387 $ 472 $ 3,770 $ 228 $ 798 $ 155 $ 6 $ 11,928 Allowance ending balance: Individually evaluated for impairment $ 129 $ — $ 31 $ 41 $ 40 $ — $ — $ — $ — $ 241 Collectively evaluated for impairment 1,634 1,349 3,356 431 3,730 228 798 155 6 11,687 Loans: Individually evaluated for impairment 919 — 6,411 170 1,769 247 34 612 — 10,162 Collectively evaluated for impairment 204,984 152,760 366,444 61,960 359,104 23,696 52,782 20,861 390 1,242,981 Ending balance $ 205,903 $ 152,760 $ 372,855 $ 62,130 $ 360,873 $ 23,943 $ 52,816 $ 21,473 $ 390 $ 1,253,143 For the year ended December 31, 2016 Commercial Construction Commercial Farmland 1-4 family Multi-family Consumer Agricultural Overdrafts Total Allowance for loan losses: Beginning balance $ 1,878 $ 1,004 $ 2,106 $ 400 $ 2,839 $ 325 $ 562 $ 138 $ 11 $ 9,263 Provision for loan losses 910 162 1,158 82 1,117 (44 ) 171 15 69 3,640 Loans charged-off (1,213 ) (9 ) — — (71 ) — (269 ) — (200 ) (1,762 ) Recoveries 17 4 — — 75 — 121 — 126 343 Ending balance $ 1,592 $ 1,161 $ 3,264 $ 482 $ 3,960 $ 281 $ 585 $ 153 $ 6 $ 11,484 Allowance ending balance: Individually evaluated for impairment $ 64 $ — $ — $ 47 $ 108 $ — $ 34 $ — $ — $ 253 Collectively evaluated for impairment 1,528 1,161 3,264 435 3,852 281 551 153 6 11,231 Loans: Individually evaluated for impairment 231 1,825 1,196 258 2,588 5 200 15 — 6,318 Collectively evaluated for impairment 223,766 127,541 366,460 62,104 360,364 26,074 53,305 18,886 317 1,238,817 Ending balance $ 223,997 $ 129,366 $ 367,656 $ 62,362 $ 362,952 $ 26,079 $ 53,505 $ 18,901 $ 317 $ 1,245,135 For the three months ended March 31, 2016 Commercial Construction Commercial Farmland 1-4 family Multi-family Consumer Agricultural Overdrafts Total Allowance for loan losses: Beginning balance $ 1,878 $ 1,004 $ 2,106 $ 400 $ 2,839 $ 325 $ 562 $ 138 $ 11 $ 9,263 Provision for loan losses (504 ) (200 ) 145 (50 ) 1,115 13 (83 ) (12 ) 26 450 Loans charged-off — — — — (14 ) — (51 ) — (39 ) (104 ) Recoveries 11 4 — — — — 18 — 23 56 Ending balance $ 1,385 $ 808 $ 2,251 $ 350 $ 3,940 $ 338 $ 446 $ 126 $ 21 $ 9,665 Allowance ending balance: Individually evaluated for impairment $ 288 $ — $ — $ 47 $ 92 $ — $ 84 $ — $ — $ 511 Collectively evaluated for impairment 1,097 808 2,251 303 3,848 338 362 126 21 9,154 Loans: Individually evaluated for impairment 3,270 39 128 283 2,038 3 235 — — 5,996 Collectively evaluated for impairment 213,659 92,792 336,871 54,038 332,385 34,652 51,317 19,808 546 1,136,068 Ending balance $ 216,929 $ 92,831 $ 336,999 $ 54,321 $ 334,423 $ 34,655 $ 51,552 $ 19,808 $ 546 $ 1,142,064 Credit Quality The Company closely monitors economic conditions and loan performance trends to manage and evaluate the exposure to credit risk. Key factors tracked by the Company and utilized in evaluating the credit quality of the loan portfolio include trends in delinquency ratios, the level of nonperforming assets, borrower’s repayment capacity, and collateral coverage. Assets are graded “pass” when the relationship exhibits acceptable credit risk and indicates repayment ability, tolerable collateral coverage and reasonable performance history. Lending relationships exhibiting potentially significant credit risk and marginal repayment ability and/or asset protection are graded “special mention.” Assets classified as “substandard” are inadequately protected by the current net worth and paying capacity of the obligor or of the collateral pledged, if any. Loans so classified must have a well-defined weakness that jeopardizes the liquidation of the debt. Substandard graded loans are characterized by the distinct possibility that the Company will sustain some loss if the deficiencies are not corrected. Assets graded “doubtful” are substandard graded loans that have added characteristics that make collection or liquidation in full improbable. The Company typically measures impairment based on the present value of expected future cash flows, discounted at the loan's effective interest rate, or based on the loan's observable market price or the fair value of the collateral if the loan is collateral-dependent. The following tables summarize the credit exposure in the consumer and commercial loan portfolios as of: March 31, 2017 Commercial and industrial Construction and development Commercial real estate Farmland 1-4 family residential Multi-family residential Consumer Agricultural Total Grade: Pass $ 200,851 $ 152,760 $ 365,789 $ 61,503 $ 354,074 $ 23,696 $ 52,308 $ 19,802 $ 1,230,783 Special mention 4,025 — 1,287 457 3,011 — 440 972 10,192 Substandard 1,027 — 5,701 170 3,745 247 397 699 11,986 Doubtful — — 78 — 43 — 61 — 182 Total $ 205,903 $ 152,760 $ 372,855 $ 62,130 $ 360,873 $ 23,943 $ 53,206 $ 21,473 $ 1,253,143 December 31, 2016 Commercial and industrial Construction and development Commercial real estate Farmland 1-4 family residential Multi-family residential Consumer Agricultural Total Grade: Pass $ 218,975 $ 127,537 $ 360,264 $ 61,713 $ 353,483 $ 25,871 $ 52,648 $ 17,965 $ 1,218,456 Special mention 4,299 4 1,927 248 4,311 — 524 478 11,791 Substandard 706 1,825 5,465 401 5,121 208 568 458 14,752 Doubtful 17 — — — 37 — 82 — 136 Total $ 223,997 $ 129,366 $ 367,656 $ 62,362 $ 362,952 $ 26,079 $ 53,822 $ 18,901 $ 1,245,135 The following tables summarize the payment status of loans in the Company’s total loan portfolio, including an aging of delinquent loans, loans 90 days or more past due continuing to accrue interest and loans classified as nonperforming as of: March 31, 2017 30 to 59 Days Past Due 60 to 89 Days Past Due 90 Days and Greater Past Due Total Past Due Current Total Loans Recorded Investment > 90 Days and Accruing Commercial and industrial 460 181 30 671 205,232 205,903 — Real estate: Construction and development 60 — — 60 152,700 152,760 — Commercial real estate 1,225 41 136 1,402 371,453 372,855 — Farmland 114 — — 114 62,016 62,130 — 1-4 family residential 3,867 323 1,183 5,373 355,500 360,873 — Multi-family residential 49 198 — 247 23,696 23,943 — Consumer 610 95 80 785 52,031 52,816 — Agricultural 188 14 14 216 21,257 21,473 — Overdrafts — — — — 390 390 — Total 6,573 852 1,443 8,868 1,244,275 1,253,143 — December 31, 2016 30 to 59 Days Past Due 60 to 89 Days Past Due 90 Days and Greater Past Due Total Past Due Current Total Recorded Investment > 90 Days and Accruing Commercial and industrial 941 105 25 1,071 222,926 223,997 — Real estate: Construction and development 73 — 1,825 1,898 127,468 129,366 — Commercial real estate 1,629 32 134 1,795 365,861 367,656 — Farmland 100 26 7 133 62,229 62,362 — 1-4 family residential 3,724 803 1,041 5,568 357,384 362,952 — Multi-family residential 207 49 — 256 25,823 26,079 — Consumer 613 205 87 905 52,600 53,505 — Agricultural 59 — 15 74 18,827 18,901 — Overdrafts — — — — 317 317 — Total 7,346 1,220 3,134 11,700 1,233,435 1,245,135 — The following table presents information regarding nonaccrual loans as of: March 31, 2017 December 31, 2016 Commercial and industrial 517 82 Real estate: Construction and development — 1,825 Commercial real estate 136 415 Farmland 163 176 1-4 family residential 1,772 1,699 Multi-family residential — 5 Consumer 165 192 Agricultural 313 15 Total 3,066 4,409 Impaired Loans and Troubled Debt Restructurings A troubled debt restructuring (“TDR”) is a restructuring in which a bank, for economic or legal reasons related to a borrower's financial difficulties, grants a concession to the borrower that it would not otherwise consider. A loan is considered impaired when, based on current information and events, it is probable that the Company will be unable to collect all amounts due from the borrower in accordance with original contractual terms of the loan. Loans with insignificant delays or insignificant short falls in the amount of payments expected to be collected are not considered to be impaired. Loans defined as individually impaired, based on applicable accounting guidance, include larger balance nonperforming loans and troubled debt restructurings. The outstanding balances of TDRs are shown below: March 31, 2017 December 31, 2016 Nonaccrual TDRs 42 90 Performing TDRs 330 415 Total 372 505 Specific reserves on TDRs 4 4 The following tables present loans by class modified as TDRs that occurred during the three months ended March 31, 2017 and 2016 : Three Months Ended March 31, 2017 Number of Contracts Pre-Modification Outstanding Recorded Investment Post-Modification Outstanding Recorded Investment Troubled Debt Restructurings: Commercial and industrial 1 34 34 1-4 family residential 1 11 11 Total 2 45 45 There were no TDRs that subsequently defaulted in 2017 . The TDRs described above did not increase the allowance for loan losses and resulted in no charge-offs during the three months ended March 31, 2017 . Three Months Ended March 31, 2016 Number of Contracts Pre-Modification Outstanding Recorded Investment Post-Modification Outstanding Recorded Investment Troubled Debt Restructurings: Consumer 3 23 23 Total 3 23 23 There were no TDRs that subsequently defaulted in 2016 . The TDRs described above did not increase the allowance for loan losses and resulted in no charge-offs during the three months ended March 31, 2016 . The following table presents information about the Company’s impaired loans as of and for the three months ended : March 31, 2017 Recorded Unpaid Related Average Interest With no related allowance recorded: Commercial and industrial $ 373 $ 373 $ — $ 159 $ 5 Real estate: Construction and development — — — 1,217 — Commercial real estate 5,893 5,893 — 4,936 73 Farmland 7 7 — 65 — 1-4 family residential 1,315 1,315 — 1,675 18 Multi-family residential 247 247 — 102 4 Consumer 34 34 — 105 1 Agricultural 612 612 — 214 13 Subtotal 8,481 8,481 — 8,473 114 With allowance recorded: Commercial and industrial 546 546 129 624 10 Real estate: Commercial real estate 518 518 31 251 3 Farmland 163 163 41 163 — 1-4 family residential 454 454 40 609 5 Consumer — — — 100 Subtotal 1,681 1,681 241 1,747 18 Total $ 10,162 $ 10,162 $ 241 $ 10,220 $ 132 The following table presents information about the Company’s impaired loans as of and for the year ended: December 31, 2016 Recorded Investment Unpaid Principal Balance Related Allowance Average Recorded Investment Interest Income Recognized With no related allowance recorded: Commercial and industrial $ 28 $ 28 $ — $ 809 $ 3 Real estate: Construction and development 1,825 1,825 — 172 84 Commercial real estate 1,196 1,196 — 871 47 Farmland 89 89 — 109 5 1-4 family residential 1,799 1,799 — 1,575 106 Multi-family residential 5 5 — 2 1 Consumer 105 105 — 89 12 Agricultural 15 15 — 68 2 Subtotal 5,062 5,062 — 3,695 260 With allowance recorded: Commercial and industrial 203 203 64 3,153 4 Real estate: Farmland 169 169 47 169 1 1-4 family residential 789 789 108 639 44 Consumer 95 95 34 155 8 Agricultural — — — 2 — Subtotal 1,256 1,256 253 4,118 57 Total $ 6,318 $ 6,318 $ 253 $ 7,813 $ 317

SECURITIES SOLD UNDER AGREEMENT

SECURITIES SOLD UNDER AGREEMENTS TO REPURCHASE AND OTHER DEBT	3 Months Ended
	Mar. 31, 2017
Debt Disclosure [Abstract]
SECURITIES SOLD UNDER AGREEMENTS TO REPURCHASE AND OTHER DEBT	SECURITIES SOLD UNDER AGREEMENTS TO REPURCHASE AND OTHER DEBT At March 31, 2017 and December 31, 2016 , securities sold under agreements to repurchase totaled $12,663 and $10,859 , respectively. On March 31, 2017 , a line of credit and amortizing note with our correspondent bank were restructured and combined into one unsecured $25,000 line of credit with an outstanding balance of $18,929 at quarter end. The line of credit bears interest at the prime rate plus 0.50% , with interest payable quarterly, and matures in March 2018. The outstanding balance of the line of credit was repaid in full upon completion of our initial public offering as described in the subsequent events in Note 1. SUBORDINATED DEBENTURES Subordinated debentures are made up of the following as of: March 31, 2017 December 31, 2016 Debentures II $ 3,093 $ 3,093 Debentures III 2,062 2,062 DCB Debentures I 5,155 5,155 Other Debentures 9,000 9,000 $ 19,310 $ 19,310 The Company has three trusts, Guaranty (TX) Capital Trust II (“Trust II”), Guaranty (TX) Capital Trust III (“Trust III”), and DCB Trust I (“Trust II”, “Trust III” and together with DCB Trust I, the “Trusts”). Upon formation, the Trusts issued pass-through securities (“TruPS”) with a liquidation value of $1,000 per share to third parties in private placements. Concurrently with the issuance of the TruPS, the Trusts issued common securities to the Company. The Trusts invested the proceeds of the sales of securities to the Company (“Debentures”). The Debentures mature approximately 30 years after the formation date, which may be shortened if certain conditions are met (including the Company having received prior approval of the Federal Reserve and any other required regulatory approvals). Trust II Trust III DCB Trust I Formation date October 30, 2002 July 25, 2006 March 29, 2007 Capital trust pass-through securities Number of shares 3,000 2,000 5,000 Original liquidation value $ 3,000 $ 2,000 $ 5,000 Common securities liquidation value 93 62 155 The securities held by the Trusts qualify as Tier I capital for the Company under Federal Reserve Board guidelines. The Federal Reserve’s guidelines restrict core capital elements (including trust preferred securities and qualifying perpetual preferred stock) to 25% of all core capital elements, net of goodwill less any associated deferred tax liability. Because the Company’s aggregate amount of trust preferred securities is less than the limit of 25% of Tier I capital, net of goodwill, the full amount is includable in Tier I capital at March 31, 2017 and December 31, 2016 . Additionally, the terms provide that trust preferred securities would no longer qualify for Tier I capital within five years of their maturity, but would be included as Tier 2 capital. However, the trust preferred securities would be amortized out of Tier 2 capital by one-fifth each year and excluded from Tier 2 capital completely during the year prior to maturity of the junior subordinated debentures. With certain exceptions, the amount of the principal and any accrued and unpaid interest on the Debentures are subordinated in right of payment to the prior payment in full of all senior indebtedness of the Company. Interest on the Debentures is payable quarterly. The interest is deferrable on a cumulative basis for up to five consecutive years following a suspension of dividend payments on all other capital stock. No principal payments are due until maturity for each of the Debentures. Debentures II Debentures III DCB Debentures I Original amount $ 3,093 $ 2,062 $ 5,155 Maturity date October 30, 2032 October 1, 2036 June 15, 2037 Interest due Quarterly Quarterly Quarterly In accordance with ASC 810, " Consolidation, " the junior subordinated debentures issued by the Company to the subsidiary trusts are shown as liabilities in the consolidated balance sheets and interest expense associated with the junior subordinated debentures is shown in the consolidated statements of earnings. Debentures II Interest is payable at a variable rate per annum, reset quarterly, equal to 3 month LIBOR plus 3.35% . On any interest payment date on or after October 30, 2012 and prior to maturity date, the Debentures II are redeemable for cash at the option of the Company, on at least 30 , but not more than 60 days’ notice, in whole or in part, at a redemption price equal to 100% of the principal amount to be redeemed, plus accrued interest to the date of redemption. Debentures III Interest was payable at a variable rate per annum, reset quarterly, equal to 3 month LIBOR plus 1.67% . On any interest payment date on or after October 1, 2016 and prior to maturity date, the Debentures III are redeemable for cash at the option of the Company, on at least 30 , but not more than 60 days’ notice, in whole or in part, at a redemption price equal to 100% of the principal amount to be redeemed, plus accrued interest to the date of redemption. DCB Debentures I Interest is payable at a variable rate per annum, reset quarterly, equal to 3 month LIBOR plus 1.80% . On any interest payment date on or after June 15, 2012 and prior to maturity date, the DCB Debentures I are redeemable for cash at the option of the Company, on at least 30 , but not more than 60 days’ notice, in whole or in part, at a redemption price equal to 100% of the principal amount to be redeemed, plus accrued interest to the date of redemption. Other Debentures In July 2015, the Company issued $4,000 in debentures, of which $3,000 were issued to directors and other related parties, which will mature in 2017 , 2018 , and 2019 . At the Company’s option, and with 30 days advanced notice to the holder, the entire principal amount and all accrued interest may be paid to the holder on or before the due date of any debenture. The redemption price is equal to 100% of the face amount of the debenture redeemed, plus all accrued interest. The debentures were issued at par value of $500 each with rates ranging from 2.50% to 4.00% and maturity dates from July 1, 2017 to January 1, 2019 . In December 2015, the Company issued $5,000 in debentures, of which $2,500 were issued to directors and other related parties, which will mature in 2018 , 2019 , and 2020 . At the Company’s option, and with 30 days advanced notice to the holder, the entire principal amount and all accrued interest may be paid to the holder on or before the due date of any debenture. The redemption price is equal to 100% of the face amount of the debenture redeemed, plus all accrued interest. The debentures were issued at par value of $500 each with rates ranging from 3.00% to 5.00% and maturity dates from July 1, 2018 to July 1, 2020 . As noted in the subsequent events in Note 1, $5,000 of the Other Debentures were repaid upon completion of our initial public offering in May 2017.

SUBORDINATED DEBENTURES

SUBORDINATED DEBENTURES	3 Months Ended
	Mar. 31, 2017
Debt Disclosure [Abstract]
SUBORDINATED DEBENTURES	SECURITIES SOLD UNDER AGREEMENTS TO REPURCHASE AND OTHER DEBT At March 31, 2017 and December 31, 2016 , securities sold under agreements to repurchase totaled $12,663 and $10,859 , respectively. On March 31, 2017 , a line of credit and amortizing note with our correspondent bank were restructured and combined into one unsecured $25,000 line of credit with an outstanding balance of $18,929 at quarter end. The line of credit bears interest at the prime rate plus 0.50% , with interest payable quarterly, and matures in March 2018. The outstanding balance of the line of credit was repaid in full upon completion of our initial public offering as described in the subsequent events in Note 1. SUBORDINATED DEBENTURES Subordinated debentures are made up of the following as of: March 31, 2017 December 31, 2016 Debentures II $ 3,093 $ 3,093 Debentures III 2,062 2,062 DCB Debentures I 5,155 5,155 Other Debentures 9,000 9,000 $ 19,310 $ 19,310 The Company has three trusts, Guaranty (TX) Capital Trust II (“Trust II”), Guaranty (TX) Capital Trust III (“Trust III”), and DCB Trust I (“Trust II”, “Trust III” and together with DCB Trust I, the “Trusts”). Upon formation, the Trusts issued pass-through securities (“TruPS”) with a liquidation value of $1,000 per share to third parties in private placements. Concurrently with the issuance of the TruPS, the Trusts issued common securities to the Company. The Trusts invested the proceeds of the sales of securities to the Company (“Debentures”). The Debentures mature approximately 30 years after the formation date, which may be shortened if certain conditions are met (including the Company having received prior approval of the Federal Reserve and any other required regulatory approvals). Trust II Trust III DCB Trust I Formation date October 30, 2002 July 25, 2006 March 29, 2007 Capital trust pass-through securities Number of shares 3,000 2,000 5,000 Original liquidation value $ 3,000 $ 2,000 $ 5,000 Common securities liquidation value 93 62 155 The securities held by the Trusts qualify as Tier I capital for the Company under Federal Reserve Board guidelines. The Federal Reserve’s guidelines restrict core capital elements (including trust preferred securities and qualifying perpetual preferred stock) to 25% of all core capital elements, net of goodwill less any associated deferred tax liability. Because the Company’s aggregate amount of trust preferred securities is less than the limit of 25% of Tier I capital, net of goodwill, the full amount is includable in Tier I capital at March 31, 2017 and December 31, 2016 . Additionally, the terms provide that trust preferred securities would no longer qualify for Tier I capital within five years of their maturity, but would be included as Tier 2 capital. However, the trust preferred securities would be amortized out of Tier 2 capital by one-fifth each year and excluded from Tier 2 capital completely during the year prior to maturity of the junior subordinated debentures. With certain exceptions, the amount of the principal and any accrued and unpaid interest on the Debentures are subordinated in right of payment to the prior payment in full of all senior indebtedness of the Company. Interest on the Debentures is payable quarterly. The interest is deferrable on a cumulative basis for up to five consecutive years following a suspension of dividend payments on all other capital stock. No principal payments are due until maturity for each of the Debentures. Debentures II Debentures III DCB Debentures I Original amount $ 3,093 $ 2,062 $ 5,155 Maturity date October 30, 2032 October 1, 2036 June 15, 2037 Interest due Quarterly Quarterly Quarterly In accordance with ASC 810, " Consolidation, " the junior subordinated debentures issued by the Company to the subsidiary trusts are shown as liabilities in the consolidated balance sheets and interest expense associated with the junior subordinated debentures is shown in the consolidated statements of earnings. Debentures II Interest is payable at a variable rate per annum, reset quarterly, equal to 3 month LIBOR plus 3.35% . On any interest payment date on or after October 30, 2012 and prior to maturity date, the Debentures II are redeemable for cash at the option of the Company, on at least 30 , but not more than 60 days’ notice, in whole or in part, at a redemption price equal to 100% of the principal amount to be redeemed, plus accrued interest to the date of redemption. Debentures III Interest was payable at a variable rate per annum, reset quarterly, equal to 3 month LIBOR plus 1.67% . On any interest payment date on or after October 1, 2016 and prior to maturity date, the Debentures III are redeemable for cash at the option of the Company, on at least 30 , but not more than 60 days’ notice, in whole or in part, at a redemption price equal to 100% of the principal amount to be redeemed, plus accrued interest to the date of redemption. DCB Debentures I Interest is payable at a variable rate per annum, reset quarterly, equal to 3 month LIBOR plus 1.80% . On any interest payment date on or after June 15, 2012 and prior to maturity date, the DCB Debentures I are redeemable for cash at the option of the Company, on at least 30 , but not more than 60 days’ notice, in whole or in part, at a redemption price equal to 100% of the principal amount to be redeemed, plus accrued interest to the date of redemption. Other Debentures In July 2015, the Company issued $4,000 in debentures, of which $3,000 were issued to directors and other related parties, which will mature in 2017 , 2018 , and 2019 . At the Company’s option, and with 30 days advanced notice to the holder, the entire principal amount and all accrued interest may be paid to the holder on or before the due date of any debenture. The redemption price is equal to 100% of the face amount of the debenture redeemed, plus all accrued interest. The debentures were issued at par value of $500 each with rates ranging from 2.50% to 4.00% and maturity dates from July 1, 2017 to January 1, 2019 . In December 2015, the Company issued $5,000 in debentures, of which $2,500 were issued to directors and other related parties, which will mature in 2018 , 2019 , and 2020 . At the Company’s option, and with 30 days advanced notice to the holder, the entire principal amount and all accrued interest may be paid to the holder on or before the due date of any debenture. The redemption price is equal to 100% of the face amount of the debenture redeemed, plus all accrued interest. The debentures were issued at par value of $500 each with rates ranging from 3.00% to 5.00% and maturity dates from July 1, 2018 to July 1, 2020 . As noted in the subsequent events in Note 1, $5,000 of the Other Debentures were repaid upon completion of our initial public offering in May 2017.

STOCK OPTIONS

STOCK OPTIONS	3 Months Ended
	Mar. 31, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
STOCK OPTIONS	STOCK OPTIONS The Company’s 2015 Equity Incentive Plan (“Stock Option Plan” or the “Plan”) executed April 15, 2015, which is shareholder-approved, amended and restated the Company’s 2014 Stock Option Plan (“Original Plan”). The maximum number of shares of common stock that may be issued pursuant to stock-based awards under the Plan equals 1,000,000 shares, all of which may be subject to incentive stock option treatment. Option awards are generally granted with an exercise price equal to the market price of the Company’s common stock at the date of grant. Currently outstanding option awards have vesting periods ranging from 5 to 10 years and have 10 -year contractual terms. The fair value of each option award is estimated on the date of grant using a closed form option valuation (Black-Scholes) model that uses the assumptions noted in the table below. Expected volatilities are based on historical volatilities of the Company’s common stock and similar peer group averages. The Company uses historical data to estimate option exercise and post-vesting termination behavior. The expected term of options granted is based on historical data and represents the period of time that options granted are expected to be outstanding, which takes in to account that the options are not transferable. The risk-free interest rate for the expected term of the option is based on U.S. Treasury yield curve in effect at the time of the grant. A summary of activity in the Plan during the three months ended March 31, 2017 and 2016 follows: Three Months Ended March 31, 2017 Number of Shares Weighted-Average Exercise Price Weighted-Average Remaining Contractual Life in Years Aggregate Intrinsic Value Outstanding at beginning of year 340,377 $ 23.43 7.34 $ 194 Granted 9,000 26.00 9.96 — Exercised (2,010 ) 11.94 3.08 28 Forfeited (1,000 ) 24.00 5.55 2 Balance, March 31, 2017 346,367 $ 23.56 7.19 $ 844 Exercisable at end of period 92,667 $ 22.91 6.46 $ 287 Three Months Ended March 31, 2016 Number of Shares Weighted-Average Exercise Price Weighted-Average Remaining Contractual Life in Years Aggregate Intrinsic Value Outstanding at beginning of year 314,391 $ 23.28 8.00 $ 225 Granted 21,000 23.00 8.79 21 Forfeited (10,400 ) 23.23 7.74 8 Balance, March 31, 2016 324,991 $ 23.27 7.86 $ 238 Exercisable at end of period 47,191 $ 20.83 6.51 $ 149 A summary of nonvested activity in the Plan during the three months ended March 31, 2017 and 2016 follows: Three Months Ended March 31, 2017 Number of Shares Weighted-Average Exercise Price Weighted-Average Remaining Contractual Life in Years Aggregate Intrinsic Value Outstanding at beginning of year 250,700 $ 23.73 7.65 $ 69 Granted 9,000 26.00 9.96 — Vested (6,000 ) 23.90 9.15 13 Balance, March 31, 2017 253,700 $ 23.80 7.46 $ 557 Three Months Ended March 31, 2016 Number of Shares Weighted-Average Exercise Price Weighted-Average Remaining Contractual Life in Years Aggregate Intrinsic Value Outstanding at beginning of year 267,200 $ 23.72 8.22 $ — Granted 21,000 23.00 8.79 21 Vested (10,400 ) 23.23 7.47 8 Balance, March 31, 2016 277,800 $ 23.68 8.09 $ 89 Information related to the Plan is as follows for the three months ended : March 31, 2017 Intrinsic value of options exercised $ 28 Cash received from options exercised 24 Tax benefit realized from options exercised — Weighted average fair value of options granted 4.30 As of March 31, 2017 , there was $995 of total unrecognized compensation cost related to nonvested stock options granted under the Plan. The cost is expected to be recognized over a weighted-average period of 4.63 years. The Company granted options under the 2015 Stock Option Plan in 2016 and 2017 . Expense of $60 and $39 was recorded during the three months ended March 31, 2017 and 2016 , respectively.

EMPLOYEE BENEFITS

EMPLOYEE BENEFITS	3 Months Ended
	Mar. 31, 2017
Retirement Benefits [Abstract]
EMPLOYEE BENEFITS	EMPLOYEE BENEFITS KSOP The Company maintains an Employee Stock Ownership Plan containing Section 401(k) provisions covering substantially all employees (“KSOP”). The plan provides for a matching contribution of up to 5% of a participant’s qualified compensation starting January 1, 2016. As of March 31, 2017, the plan included a put option, which is a right to demand that the sponsor redeem shares of employer stock distributed to the participant under the terms of the plan, for which there is no public market for such shares, with an established cash price. This put option was extinguished upon completion of our initial public offering and listing of our common stock on the NASDAQ Global Select Market in May 2017, as described in Note 1. Total contributions accrued or paid during the three months ended March 31, 2017 and 2016 totaled $226 and $234 , respectively. Benefits under the KSOP generally are distributed to participants in the form of cash, although participants have the right to receive distributions in the form of shares of or common stock. Because the Company’s common stock was not yet actively traded as of March 31, 2017, the participants could demand (in accordance with the terms of the KSOP and applicable law) that the Company repurchase any shares of common stock distributed to them at the estimated fair value. The fair value of shares of common stock, held by the KSOP, was deducted from permanent shareholders’ equity in the consolidated balance sheets, and reflected in a line item below liabilities and above shareholders’ equity. As of March 31, 2017, this presentation was necessary in order to recognize the put option within the KSOP-owned shares, consistent with SEC guidelines, because the Company was not yet publicly traded. The Company used a valuation by an external third party to determine the maximum possible cash obligation related to those securities. Increases or decreases in the value of the cash obligation were included in a separate line item in the statements of changes in shareholders’ equity. The fair value of allocated and unallocated shares subject to the repurchase obligation totaled $34,300 and $31,661 at March 31, 2017 and December 31, 2016 , respectively. As of March 31, 2017 and December 31, 2016 , the number of shares held by the KSOP was 1,319,225 . Of these shares, there were 50,000 shares unallocated to plan participants as of March 31, 2017 and December 31, 2016 . In the three months ended March 31, 2017 and 2016 , the Company did not repurchase any shares from KSOP participants that received distributions of shares from the KSOP which were subject to the put option that applied to the KSOP shares before we were publicly traded. All shares held by the KSOP were treated as outstanding at each of the respective period ends. Supplemental Retirement Plan The Company maintains a non-qualified, non-contributory supplemental retirement plan. The plan covers a retired officer to provide benefits equal to amounts payable under the Company’s retirement plan and certain social security benefits to aggregate a predetermined percentage of the officer’s final five -year average salary. The plan is non-funded. There were no amounts expensed during the three months ended March 31, 2017 and 2016 . The recorded obligation was approximately $0 and $5 as of March 31, 2017 and December 31, 2016 , respectively and is included in accrued interest and other liabilities on the consolidated balance sheets. Executive Incentive Retirement Plan The Company established a non-qualified, non-contributory executive incentive retirement plan covering a selected group of key personnel to provide benefits equal to amounts computed under an “award criteria” at various targeted salary levels as adjusted for annual earnings performance of the Company. The plan is non-funded. The Executive Incentive Retirement Plan, the Company has purchased life insurance policies on the respective officers. The cash surrender value of life insurance policies held by the Company totaled $17,922 and $17,804 as of March 31, 2017 and December 31, 2016 , respectively. Expense related to these plans totaled $256 and $196 for the three months ended March 31, 2017 and 2016 , respectively, and is included in employee compensation and benefits on the consolidated statements of earnings. The recorded liability totaled approximately $2,251 and $2,002 as of March 31, 2017 and December 31, 2016 , respectively and is included in accrued interest and other liabilities on the consolidated balance sheets. Bonus Plan The Company has a Bonus Plan that rewards officers and employees based on performance of individual business units of the Company. Earnings and growth performance goals for each business unit and for the Company as a whole are established at the beginning of the calendar year and approved annually by the board of directors. The Bonus Plan provides for a predetermined bonus amount to be contributed to the employee bonus pool based on (i) earnings target and growth for individual business units and (ii) achieving certain pre-tax return on average equity and pre-tax return on average asset levels for the Company as a whole. These bonus amounts are established annually by our board of directors. The bonus expense under this plan for the three months ended March 31, 2017 and 2016 totaled $581 and $499 , respectively and is included in employee compensation and benefits on the consolidated statements of earnings.

INCOME TAXES

INCOME TAXES	3 Months Ended
	Mar. 31, 2017
Income Tax Disclosure [Abstract]
INCOME TAXES	INCOME TAXES Income tax expenses were as follows for: Three Months Ended March 31, 2017 2016 Income tax expense for the period $ 1,312 $ 1,090 Effective tax rate 27.19 % 28.93 % The effective tax rates differ from the statutory federal tax rate of 35% largely due to tax exempt interest income earned on certain investment securities and loans and the nontaxable earnings on bank owned life insurance.

DERIVATIVE FINANCIAL INSTRUMENT

DERIVATIVE FINANCIAL INSTRUMENTS	3 Months Ended
	Mar. 31, 2017
Derivative Instruments and Hedging Activities Disclosure [Abstract]
DERIVATIVE FINANCIAL INSTRUMENTS	DERIVATIVE FINANCIAL INSTRUMENTS The Company utilizes certain derivative financial instruments. Stand-alone derivative financial instruments such as interest rate swaps, are used to economically hedge interest rate risk related to the Company’s liabilities. These derivative instruments involve both credit and market risk. The notional amounts are amounts on which calculations, payments, and the value of the derivative are based. Notional amounts do not represent direct credit exposures. Direct credit exposure is limited to the net difference between the calculated amounts to be received and paid, if any. Such difference, which represents the fair value of the derivative instruments, is reflected on the Company’s consolidated balance sheet in other liabilities. The Company is exposed to credit related losses in the event of nonperformance by the counterparties to those agreements. The Company controls the credit risk of its financial contracts through credit approvals, limits and monitoring procedures, and does not expect any counterparties to fail their obligations. The Company entered into interest rate swaps to receive payments at a fixed rate in exchange for paying a floating rate on the debentures discussed in Note 6. Management believes that entering into the interest rate swaps exposed the Company to variability in their fair value due to changes in the level of interest rates. It is the Company’s objective to hedge the change in fair value of floating rate debentures at coverage levels that are appropriate, given anticipated or existing interest rate levels and other market considerations, as well as the relationship of change in this liability to other liabilities of the Company. To meet this objective, the Company utilizes interest rate swaps as an asset/liability management strategy to hedge the change in value of the cash flows due to changes in expected interest rate assumptions. Interest rate swaps with notional amounts totaling $5,000 as of March 31, 2017 and December 31, 2016 , were designated as cash flow hedges of the debentures and were determined to be fully effective during all periods presented. As such, no amount of ineffectiveness has been included in net income. Therefore, the aggregate fair value of the swaps is recorded in accrued interest and other liabilities within the consolidated balance sheets with changes in fair value recorded in other comprehensive income. The amount included in accumulated other comprehensive income would be reclassified to current earnings should the hedges no longer be considered effective. The Company expects the hedges to remain fully effective during the remaining terms of the swaps. The information pertaining to outstanding interest rate swap agreements used to hedge floating rate debentures was as follows as of: March 31, 2017: Notional Amount Pay Rate Receive Rate Effective Date Maturity in Years Unrealized Losses $ 2,000 5.979 % 3 month LIBOR plus 1.67% October 1, 2016 9.01 $ 329 $ 3,000 7.505 % 3 month LIBOR plus 3.35% October 30, 2012 5.59 $ 331 December 31, 2016: Notional Amount Pay Rate Receive Rate Effective Date Maturity in Years Unrealized Losses $ 2,000 5.979 % 3 month LIBOR plus 1.67% October 1, 2016 9.25 $ 342 $ 3,000 7.505 % 3 month LIBOR plus 3.35% October 30, 2012 5.83 $ 353 Interest expense recorded on these swap transactions totaled $207 and $222 during the three months ended March 31, 2017 and 2016 , respectively, and is reported as a component of interest expense on the debentures. At March 31, 2017 , the Company expected none of the unrealized loss to be reclassified as a reduction of interest expense during the remainder of 2017 .

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	3 Months Ended
	Mar. 31, 2017
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	COMMITMENTS AND CONTINGENCIES In the normal course of business, the Company enters into various transactions, which, in accordance with accounting principles generally accepted in the United States of America, are not included in the consolidated balance sheets. These transactions are referred to as “off-balance sheet commitments.” The Company enters into these transactions to meet the financing needs of its customers. These transactions include commitments to extend credit and letters of credit, which involve elements of credit risk in excess of the amounts recognized in the consolidated balance sheets. The Company minimizes its exposure to loss under these commitments by subjecting them to credit approval and monitoring procedures. The Company enters into contractual commitments to extend credit, normally with fixed expiration dates or termination clauses, at specified rates and for specific purposes. Customers use credit commitments to ensure that funds will be available for working capital purposes, for capital expenditures and to ensure access to funds at specified terms and conditions. Substantially all of the Company’s commitments to extend credit are contingent upon customers maintaining specific credit standards at the time of loan funding. Management assesses the credit risk associated with certain commitments to extend credit in determining the level of the allowance for credit losses. Letters of credit are written conditional commitments issued by the Company to guarantee the performance of a customer to a third party. The Company’s policies generally require that letters of credit arrangements contain security and debt covenants similar to those contained in loan agreements. In the event the customer does not perform in accordance with the terms of the agreement with the third party, the Company would be required to fund the commitment. The maximum potential amount of future payments the Company could be required to make is represented by the contractual amount shown in the table below. If the commitment were funded, the Company would be entitled to seek recovery from the customer. As of March 31, 2017 and December 31, 2016 , no amounts have been recorded as liabilities for the Bank’s potential obligations under these guarantees. Commitments and letters of credit outstanding were as follows as of: Contract or Notional Amount March 31, 2017 December 31, 2016 Commitments to extend credit $ 350,323 $ 297,607 Letters of credit 9,113 8,879 Litigation The Company is involved in certain claims and lawsuits occurring in the normal course of business. Management, after consultation with legal counsel, does not believe that the outcome of these actions, if determined adversely, would have a material impact on the consolidated financial statements of the Company. FHLB Letters of Credit The Company, at March 31, 2017 , had letters of credit of $77,000 pledged to secure public deposits, repurchase agreements, and for other purposes required or permitted by law.

REGULATORY MATTERS

REGULATORY MATTERS	3 Months Ended
	Mar. 31, 2017
Banking and Thrift [Abstract]
REGULATORY MATTERS	REGULATORY MATTERS Under banking law, there are legal restrictions limiting the amount of dividends the Company can declare. Approval of the regulatory authorities is required if the effect of the dividends declared would cause regulatory capital of the Company to fall below specified minimum levels. The Company on a consolidated basis and the Bank are subject to various regulatory capital requirements administered by federal banking agencies. Failure to meet minimum capital requirements can initiate certain mandatory and possibly additional discretionary actions by regulators that, if undertaken, could have a direct material effect on the Company’s financial statements. Under capital adequacy guidelines and the regulatory framework for prompt corrective action, the Company must meet specific capital guidelines that involve quantitative measures of the Company’s assets, liabilities, and certain off balance sheet items as calculated under regulatory accounting practices. The Company’s capital amounts and classification are also subject to qualitative judgments by the regulators about components, risk weightings, and other factors. A comparison of the Company’s and Bank’s actual capital amounts and ratios to required capital amounts and ratios are presented in the following tables as of: Actual Minimum Required For Capital Adequacy Purposes To Be Well Capitalized Under Prompt Corrective Action Provisions Amount Ratio Amount Ratio Amount Ratio March 31, 2017 Total capital to risk-weighted assets: Consolidated $ 152,967 10.84 % $ 112,877 8.00 % n/a Bank 177,589 12.60 % 112,778 8.00 % $ 140,973 10.00 % Tier 1 capital to risk-weighted assets: Consolidated 141,039 10.00 % 84,658 6.00 % n/a Bank 165,661 11.75 % 84,584 6.00 % 112,778 8.00 % Tier 1 capital to average assets: Consolidated 141,039 7.66 % 73,640 4.00 % n/a Bank 165,661 9.01 % 73,572 4.00 % 91,965 5.00 % Common equity tier 1 risk-based capital: Consolidated 130,729 9.27 % 63,494 4.50 % n/a Bank 165,661 11.75 % 63,438 4.50 % 91,632 6.50 % Actual Minimum Required For Capital Adequacy Purposes To Be Well Capitalized Under Prompt Corrective Action Provisions Amount Ratio Amount Ratio Amount Ratio December 31, 2016 Total capital to risk-weighted assets: Consolidated $ 149,468 10.86 % $ 110,083 8.00 % n/a Bank 173,528 12.63 % 109,947 8.00 % $ 137,434 10.00 % Tier 1 capital to risk-weighted assets: Consolidated 137,984 10.03 % 82,562 6.00 % n/a Bank 162,044 11.79 % 82,460 6.00 % 109,947 8.00 % Tier 1 capital to average assets: Consolidated 137,984 7.71 % 71,560 4.00 % n/a Bank 162,044 9.06 % 71,505 4.00 % 89,381 5.00 % Common equity tier 1 risk-based capital: Consolidated 127,674 9.28 % 61,922 4.50 % n/a Bank 162,044 11.79 % 61,845 4.50 % 89,332 6.50 % In July 2013, the Federal Reserve published final rules for the adoption of the Basel III regulatory capital framework (the “Basel III Capital Rules”). The Basel III Capital Rules, among other things, (i) introduce a new capital measure called “Common Equity Tier I” (“CETI”), (ii) specify that Tier I capital consist of Common Equity Tier I and “Additional Tier I Capital” instruments meeting specified requirements, (iii) define Common Equity Tier I narrowly by requiring that most deductions/adjustments to regulatory capital measures be made to Common Equity Tier I and not to the other components of capital and (iv) expand the scope of the deductions/adjustments as compared to existing regulations. The Basel III Capital Rules became effective for the Company on January 1, 2015, with certain transition provisions to be fully phased in by January 1, 2019. Starting in January 2016, the implementation of the capital conservation buffer will be effective for the Company starting at the 0.625% level and increasing 0.625% each year thereafter, until it reaches 2.5% on January 1, 2019. The capital conservation buffer is designed to absorb losses during periods of economic stress and effectively increases the minimum required risk-weighted capital ratios. Failure to meet the full amount of the buffer will result in restrictions on the Company’s ability to make capital distributions, including dividend payments and stock repurchases, and to pay discretionary bonuses to executive officers. Quantitative measures established by regulation to ensure capital adequacy require the Bank to maintain minimum amounts and ratios (set forth in the table below) of total, CETI and Tier I capital (as defined in the regulations) to risk-weighted assets (as defined), ad of Tier I capital (as defined) to average assets (as defined). Management believes, as of March 31, 2017 and December 31, 2016 that the Bank met all capital adequacy requirements to which it was subject. As of March 31, 2017 and December 31, 2016 , the Company’s capital ratios exceeded those levels necessary to be categorized as “well capitalized” under the regulatory framework for prompt corrective action. To be categorized as “well capitalized”, the Company must maintain minimum total risk-based, CETI, Tier 1 risk-based and Tier I leverage ratios as set forth in the table. There are no conditions or events since March 31, 2017 that management believes have changed the Company’s category. The Federal Reserve’s guidelines regarding the capital treatment of trust preferred securities limits restricted core capital elements (including trust preferred securities and qualifying perpetual preferred stock) to 25% of all core capital elements, net of goodwill less any associated deferred tax liability. Because the Company’s aggregate amount of trust preferred securities is less than the limit of 25% of Tier I capital, net of goodwill, the rules permit the inclusion of $10,310 of trust preferred securities in Tier I capital at March 31, 2017 and December 31, 2016 . Additionally, the rules provide that trust preferred securities would no longer qualify for Tier I capital within five years of their maturity, but would be included as Tier 2 capital. However, the trust preferred securities would be amortized out of Tier 2 capital by one-fifth each year and excluded from Tier 2 capital completely during the year prior to maturity of the subordinated debentures. Dividends paid by the Company are mainly provided by dividends from its subsidiaries. However, certain regulatory restrictions exist regarding the ability of its bank subsidiary to transfer funds to the Company in the form of cash dividends, loans or advances. The amount of dividends that a subsidiary bank organized as a national banking association, such as the Bank, may declare in a calendar year is the subsidiary bank’s net profits for that year combined with its retained net profits for the preceding two years.

FAIR VALUE

FAIR VALUE	3 Months Ended
	Mar. 31, 2017
Fair Value Disclosures [Abstract]
FAIR VALUE	FAIR VALUE Fair value is the exchange price that would be received for an asset or paid to transfer a liability (exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. There are three levels of inputs that may be used to measure fair values: Level 1 - Quoted prices (unadjusted) for identical assets or liabilities in active markets that the entity has the ability to access as of the measurement date. Level 2 - Significant other observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data. Level 3 - Significant unobservable inputs that reflect a company’s own assumptions about the assumptions that market participants would use in pricing an asset or liability. The Company used the following methods and significant assumptions to estimate fair value: Marketable Securities : The fair values for marketable securities are determined by quoted market prices, if available (Level 1). For securities where quoted prices are not available, fair values are calculated based on market prices of similar securities (Level 2). For securities where quoted prices or market prices of similar securities are not available, fair values are calculated using discounted cash flows or other market indicators (Level 3). Loans Held For Sale: Loans held for sale are carried at the lower of cost or fair value, which is evaluated on a pool-level basis. The fair value of loans held for sale is determined using quoted prices for similar assets, adjusted for specific attributes of that loan or other observable market data, such as outstanding commitments from third party investors (Level 2). Derivative Instruments : The fair values of derivatives are based on valuation models using observable market data as of the measurement date (Level 2). Impaired Loans : The fair value of impaired loans with specific allocations of the allowance for loan losses is generally based on the present value of estimated future cash flows using the loan's existing rate or, if repayment is expected solely from the collateral, the fair value of collateral, less costs to sell, is determined using recent real estate appraisals. These appraisals may utilize a single valuation approach or a combination of approaches including comparable sales and the income approach. Adjustments are routinely made in the appraisal process by the independent appraisers to adjust for differences between the comparable sales and income data available. Such adjustments are usually significant (Level 3). Non-real estate collateral may be valued using an appraisal, net book value per the borrower’s financial statements, or aging reports, adjusted or discounted based on management’s historical knowledge, changes in market conditions from the time of the valuation, and management’s expertise and knowledge of the client and client’s business (Level 3). Impaired loans are evaluated on a quarterly basis for additional impairment and adjusted accordingly. Other Real Estate Owned : Assets acquired through or instead of loan foreclosure are initially recorded at fair value less costs to sell when acquired, establishing a new cost basis. These assets are subsequently accounted for at lower of cost or fair value less estimated costs to sell. Fair value is commonly based on recent real estate appraisals which are updated no less frequently than annually. These appraisals may utilize a single valuation approach or a combination of approaches including comparable sales and the income approach. Adjustments are routinely made in the appraisal process by the independent appraisers to adjust for differences between the comparable sales and income data available. Real estate owned properties are evaluated on a quarterly basis for additional impairment and adjusted accordingly (Level 3). The following tables summarize quantitative disclosures about the fair value measurements for each category of financial assets (liabilities) carried at fair value: As of March 31, 2017 Fair Value Quoted Prices in Active Markets for Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) Significant Other Unobservable Inputs (Level 3) Assets (liabilities) at fair value on a recurring basis: Available for sale securities Mortgage-backed securities $ 79,545 $ — $ 79,545 $ — Collateralized mortgage obligations 102,467 — 102,467 — Municipal securities 7,278 — 7,278 — Corporate bonds 25,173 — 25,173 — Derivative instruments (661 ) — (661 ) — Assets at fair value on a nonrecurring basis: Impaired loans 9,921 — — 9,921 Other real estate owned 1,637 — — 1,637 As of December 31, 2016 Fair Value Quoted Prices in Active Markets for Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) Significant Other Unobservable Inputs (Level 3) Assets (liabilities) at fair value on a recurring basis: Available for sale securities Mortgage-backed securities $ 59,690 $ — $ 59,690 $ — Collateralized mortgage obligations 65,133 — 65,133 — Corporate bonds 24,883 — 24,883 — U.S. treasury securities — — — — Derivative instruments (695 ) — (695 ) — Assets at fair value on a nonrecurring basis: Impaired loans 6,065 — — 6,065 Other real estate owned 1,692 — — 1,692 There were no transfers between Level 2 and Level 3 during 2017 or 2016 . Nonfinancial Assets and Nonfinancial Liabilities Nonfinancial assets measured at fair value on a nonrecurring basis during the three months ended March 31, 2017 and 2016 include certain foreclosed assets which, upon initial recognition, were remeasured and reported at fair value through a charge-off to the allowance for loan losses and certain foreclosed assets which, subsequent to their initial recognition, were remeasured at fair value through a write-down included in current earnings. The fair value of a foreclosed asset is estimated using Level 2 inputs based on observable market data or Level 3 inputs based on customized discounting criteria. The following table presents foreclosed assets that were remeasured and recorded at fair value as of: March 31, 2017 December 31, 2016 March 31, 2016 Foreclosed assets remeasured at initial recognition: Carrying value of foreclosed assets prior to remeasurement $ 87 $ 78 $ 134 Charge-offs recognized in the allowance for loan losses (78 ) (11 ) (14 ) Fair value of foreclosed assets remeasured at initial recognition $ 9 $ 67 $ 120 Foreclosed assets remeasured subsequent to initial recognition: Carrying value of foreclosed assets prior to remeasurement $ — $ 170 $ — Write-downs included in collection and other real estate owned expense — (69 ) — Fair value of foreclosed assets remeasured subsequent to initial recognition $ — $ 101 $ — The following tables present quantitative information about nonrecurring Level 3 fair value measurements as of: Fair Value Valuation Technique(s) Unobservable Input(s) Range (Weighted Average) March 31, 2017 Impaired loans $ 9,921 Fair value of collateral - sales comparison approach Selling costs or other normal adjustments: Real estate Equipment 10%-20% (16%) 10%-20% (14%) Other real estate owned $ 1,637 Appraisal value of collateral Selling costs or other normal adjustments 10%-20% (16%) Fair Value Valuation Technique(s) Unobservable Input(s) Range (Weighted Average) December 31, 2016 Impaired loans $ 6,065 Fair value of collateral - sales comparison approach Selling costs or other normal adjustments: Real estate Equipment 10%-20% (16%) 40%-50% (42%) Other real estate owned $ 1,692 Appraisal value of collateral Selling costs or other normal adjustments 10%-20% (16%) The carrying amounts and estimated fair values of financial instruments, not previously in this note, as of March 31, 2017 and December 31, 2016 are as follows: Fair value measurements as of Carrying Amount Level 1 Inputs Level 2 Inputs Level 3 Inputs Total Fair Value Financial assets: Cash, due from banks, federal funds sold and interest-bearing deposits $ 143,757 $ 115,751 $ 28,006 $ — $ 143,757 Marketable securities held to maturity 185,837 — 184,412 — 184,412 Loans, net 1,241,215 — — 1,246,011 1,246,011 Accrued interest receivable 6,304 — 6,304 — 6,304 Nonmarketable equity securities 7,285 — 7,285 — 7,285 Cash surrender value of life insurance 17,922 — 17,922 — 17,922 Financial liabilities: Deposits $ 1,671,171 $ 1,335,456 $ 336,371 $ — $ 1,671,827 Securities sold under repurchase agreements 12,663 — 12,663 — 12,663 Accrued interest payable 1,010 — 1,010 — 1,010 Other debt 18,929 — 18,929 — 18,929 Federal Home Loan Bank advances 25,165 — 25,163 — 25,163 Subordinated debentures 19,310 — 16,852 — 16,852 Fair value measurements as of Carrying Amount Level 1 Inputs Level 2 Inputs Level 3 Inputs Total Fair Value Financial assets: Cash, due from banks, federal funds sold and interest-bearing deposits $ 127,543 $ 100,205 $ 27,338 $ — $ 127,543 Marketable securities held to maturity 189,371 — 186,155 — 186,155 Loans, net 1,233,651 — — 1,235,306 1,235,306 Accrued interest receivable 7,419 — 7,419 — 7,419 Nonmarketable equity securities 10,500 — 10,500 — 10,500 Cash surrender value of life insurance 17,804 — 17,804 — 17,804 Financial liabilities: Deposits $ 1,576,791 $ 1,234,875 $ 342,615 $ — $ 1,577,490 Securities sold under repurchase agreements 10,859 — 10,859 — 10,859 Accrued interest payable 889 — 889 — 889 Other debt 18,286 — 18,286 — 18,286 Federal Home Loan Bank advances 55,170 — 55,160 — 55,160 Subordinated debentures 19,310 — 16,809 — 16,809 The methods and assumptions, not previously presented, used to estimate fair values are described as follows: Cash and Cash Equivalents The carrying amounts of cash and short-term instruments approximate fair values (Level 1). Loans, net The fair value of fixed-rate loans and variable-rate loans that reprice on an infrequent basis is estimated by discounting future cash flows using the current interest rates at which similar loans with similar terms would be made to borrowers of similar credit quality (Level 3). Cash Surrender Value of Life Insurance The carrying amounts of bank-owned life insurance approximate their fair value. Nonmarketable Equity Securities It is not practical to determine the fair value of Independent Bankers Financial Corporation, Federal Home Loan Bank, Federal Reserve Bank and other stock due to restrictions placed on its transferability. Deposits and Securities Sold Under Repurchase Agreements The fair values disclosed for demand deposits (e.g., interest and non-interest checking, passbook savings, and certain types of money market accounts) are, by definition, equal to the amount payable on demand at the reporting date (i.e., their carrying amount) (Level 1). The fair values of deposit liabilities with defined maturities are estimated by discounting future cash flows using interest rates currently offered for deposits of similar remaining maturities (Level 2). Other Borrowings The fair value of borrowings, consisting of lines of credit, Federal Home Loan Bank advances and Subordinated debentures is estimated by discounting future cash flows using currently available rates for similar financing (Level 2). Accrued Interest Receivable/Payable The carrying amounts of accrued interest approximate their fair values (Level 2). Off-balance Sheet Instruments Fair values for off-balance sheet, credit-related financial instruments are based on fees currently charged to enter into similar agreements, taking into account the remaining terms of the agreements and the counterparties’ credit standing. The fair value of commitments is not material.

EARNINGS PER SHARE

EARNINGS PER SHARE	3 Months Ended
	Mar. 31, 2017
Earnings Per Share [Abstract]
EARNINGS PER SHARE	EARNINGS PER SHARE Basic earnings per share is computed by dividing net earnings available to common shareholders by the weighted-average common shares outstanding for the period. Diluted earnings per share reflects the maximum potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock and would then share in the net earnings of the Company. Dilutive share equivalents include stock-based awards issued to employees. Stock options granted by the Company are treated as potential shares in computing earnings per share. Diluted shares outstanding include the dilutive effect of in-the-money awards which is calculated based on the average share price for each fiscal period using the treasury stock method. Under the treasury stock method, the amount that the employee must pay for exercising stock options, the amount of compensation cost for future service that the Company has not yet recognized, and the amount of tax impact that would be recorded in additional paid-in capital when the award becomes deductible are assumed to be used to repurchase shares. The computations of basic and diluted earnings per share for the Company were as follows as of: March 31, 2017 March 31, 2016 Numerator: Net earnings (basic) $ 3,516 $ 2,677 Net earnings (diluted) $ 3,516 $ 2,677 Denominator: Weighted-average shares outstanding (basic) 8,751,945 8,968,052 Effect of dilutive securities: Common stock equivalent shares from stock options 32,465 9,914 Weighted-average shares outstanding (diluted) 8,784,410 8,977,966 Net earnings per share Basic $ 0.40 $ 0.30 Diluted $ 0.40 $ 0.30

SUMMARY OF SIGNIFICANT ACCOUN22

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	3 Months Ended
	Mar. 31, 2017
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation : The consolidated financial statements in this Quarterly Report on Form 10-Q (this “Report”) include the accounts of Guaranty, the Bank, and their respective other direct and indirect subsidiaries and any other entities in which Guaranty has a controlling interest. The Bank has five wholly-owned non-bank subsidiaries, Guaranty Company, Inc., G B COM, INC., 2800 South Texas Avenue LLC, Pin Oak Realty Holdings, Inc. and Pin Oak Energy Holdings, LLC. All significant intercompany balances and transactions have been eliminated in consolidation. The accounting and financial reporting policies we follow conform, in all material respects, to accounting principles generally accepted in the United States of America (“GAAP”) and to general practices within the financial services industry. The consolidated financial statements in this Report have not been audited by an independent registered public accounting firm, but in the opinion of management, reflect all adjustments necessary for a fair presentation of our financial position and results of operations. All such adjustments were of a normal and recurring nature. The consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States for interim financial information and with the instructions to Form 10-Q adopted by the Securities and Exchange Commission (“SEC”). Accordingly, the financial statements do not include all of the information and footnotes required by GAAP for complete financial statements and should be read in conjunction with our consolidated financial statements, and notes thereto, for the year ended December 31, 2016 , included in our Prospectus filed with the SEC under Rule 424(b) on May 9, 2017, relating to our initial public offering. Operating results for the interim periods disclosed herein are not necessarily indicative of the results that may be expected for a full year or any future period. All dollar amounts referenced and discussed in the notes to the consolidated financial statements in this Report are presented in thousands, unless noted otherwise. The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. These estimates and assumptions may also affect disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates. Unaudited Pro Forma Financial Information - KSOP Repurchase Right : In accordance with applicable provisions of the Internal Revenue Code, the terms of our employee stock ownership plan with 401(k) provisions (“KSOP”), provided that, for so long as we were a privately-held company, KSOP participants would have the right, for a specified period of time, to require us to repurchase shares of our common stock that are distributed to them by the KSOP. This repurchase obligation terminated upon the consummation of our initial public offering and listing of our common stock on the NASDAQ Global Select Market in May 2017. However, because we were privately-held during the periods covered by the Report, the shares of common stock held by the KSOP are reflected in our consolidated balance sheet as a line item called “KSOP-owned shares,” appearing between total liabilities and shareholders’ equity. As a result, the KSOP-owned shares are deducted from shareholders’ equity in our consolidated balance sheet for the periods included in this Report. The consolidated balance sheet in this Report includes a pro forma column, which assumes that the KSOP repurchase obligation has terminated as of the date presented in the Report. For all periods following our initial public offering and continued listing of our common stock on the NASDAQ Global Select Market, the KSOP-owned shares will be included in, and not be deducted from, shareholders’ equity.
Subsequent Events	Subsequent Events :
Recent Accounting Pronouncements	Recent Accounting Pronouncements: In January 2017, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update (“ASU”) 2017-01, Business Combinations (Topic 805): Clarifying the Definition of a Business . The ASU is intended to clarify the definition of a business with the objective of adding guidance to assist entities with evaluating whether transactions should be accounted for as acquisitions (or disposals) of assets or businesses. In addition, the amendments in this update provide a detailed framework to assist entities in evaluating whether a set of assets and activities constitutes a business, as well as clarify the definition of the term output so the term is consistent with how outputs are described in Topic 606. ASU 2017-01 is effective for public companies for annual periods beginning after December 15, 2017, including interim periods within those periods. In January 2017, the FASB issued ASU 2017-04, Intangibles - Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment . This ASU simplifies the accounting for goodwill impairment for all entities by requiring impairment changes to be based on the first step in today’s two-step impairment test, thus eliminating step two from the goodwill impairment test. In addition, the amendment eliminates the requirements for any reporting unit with a zero or negative carrying amount to perform a qualitative assessment and, if it fails that qualitative test, to perform step two of the goodwill impairment test. For pubic companies, ASU 2017-04 is effective for fiscal years beginning after December 15, 2019 with early adoption permitted for interim or annual goodwill impairment tests performed on testing dates after January 1, 2017. The Company is in process of evaluating the impact of this pronouncement, which is not expected to have a significant impact on the consolidated financial statements. In November 2016, the FASB issued ASU 2016-18, Statement of Cash Flows (Topic 230): Restricted Cash , which requires that the statement of cash flows explain the change during the period in the total of cash, cash equivalents, and amounts generally described as restricted cash or restricted cash equivalents. For public companies, ASU 2016-18 is effective for fiscal years beginning after December 15, 2017, and interim periods within those fiscal years. Early adoption is permitted. The Company is in process of evaluating the impact of this pronouncement, which is not expected to have a significant impact on the consolidated financial statements. In August 2016, the FASB issued ASU 2016-15, Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments , to address diversity in how certain cash receipts and cash payments are presented and classified in the statement of cash flows. The amendments provide guidance on the following nine specific cash flow issues: 1) debt prepayment or debt extinguishment costs; 2) settlement of zero-coupon debt instruments or other debt instruments with coupon interest rates that are insignificant in relation to the effective interest rate of the borrowing; 3) contingent consideration payments made after a business combination; 4) proceeds from the settlement of insurance claims; 5) proceeds from the settlement of corporate-owned life insurance policies, including bank-owned; 6) life insurance policies; 7) distributions received from equity method investees; 8) beneficial interests in securitization transactions; and 9) separately identifiable cash flows and application of the predominance principle. The amendments are effective for public companies for fiscal years beginning after December 31, 2017, and interim periods within those fiscal years. Early adoption is permitted, including adoption in an interim period. The Company does not expect the adoption of this guidance to be material to the consolidated financial statements. In June 2016, the FASB issued ASU 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments , which sets forth a "current expected credit loss" ("CECL") model requiring the Company to measure all expected credit losses for financial instruments held at the reporting date based on historical experience, current conditions and reasonable supportable forecasts. This replaces the existing incurred loss model and is applicable to the measurement of credit losses on financial assets measured at amortized cost and applies to some off-balance sheet credit exposures. For public companies, the amendments in this update are effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. The Company is currently in the process of assembling a transition team to assess the adoption of this ASU, which will develop a project plan regarding implementation. In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842) . The FASB issued this ASU to increase transparency and comparability among organizations by recognizing lease assets and lease liabilities on the balance sheet by lessees for those leases classified as operating leases under current U.S. GAAP and disclosing key information about leasing arrangements. The amendments in this ASU are effective for public companies for annual periods, and interim periods within those annual periods, beginning after December 15, 2018. Early application of this ASU is permitted for all entities. The Company is currently evaluating the impact of adopting the new guidance on its consolidated financial statements. In January 2016, the FASB issued ASU 2016-01, Financial Instruments - Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Liabilities , which is intended to improve the recognition and measurement of financial instruments by requiring: equity investments (other than equity method or consolidation) to be measured at fair value with changes in fair value recognized in net income; public business entities to use the exit price notion when measuring the fair value of financial instruments for disclosure purposes; separate presentation of financial assets and financial liabilities by measurement category and form of financial asset (i.e., securities or loans and receivables) on the balance sheet or the accompanying notes to the financial statements; eliminating the requirement to disclose the fair value of financial instruments measured at amortized cost for organizations that are not public business entities; eliminating the requirement for public business entities to disclose the method(s) and significant assumptions used to estimate the fair value that is required to be disclosed for financial instruments measured at amortized cost on the balance sheet; and requiring a reporting organization to present separately in other comprehensive income the portion of the total change in the fair value of a liability resulting from a change in the instrument-specific credit risk (also referred to as “own credit”) when the organization has elected to measure the liability at fair value in accordance with the fair value option for financial instruments. This ASU is effective for public companies for fiscal years beginning after December 15, 2017, including interim periods within those fiscal years. This ASU permits early adoption of the instrument-specific credit risk provision. The Company is currently evaluating the impact of adopting the new guidance on its consolidated financial statements. In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers (Topic 606), followed by various amendments : ASU 2015-14, Revenue from Contracts with Customers (Topic 606): Deferral of the Effective Date, ASU 2016-08, Revenue from Contracts with Customers (Topic 606): Principal versus Agent Considerations (Reporting Revenue Gross versus Net), ASU 2016-10, Revenue from Contracts with Customers (Topic 606): Identifying Performance Obligations and Licensing, ASU 2016-11, Revenue Recognition (Topic 605) and Derivatives and Hedging (Topic 815): Rescission of SEC Guidance Because of Accounting Standards Updates 2014-09 and 2014-16 Pursuant to Staff Announcements at the March 3, 2016 EITF Meeting, and ASU 2016-12, Revenue from Contracts with Customers (Topic 606): Narrow-Scope Improvements and Practical Expedients. The amendments in these updates amend existing guidance related to revenue from contracts with customers. The amendments supersede and replace nearly all existing revenue recognition guidance, including industry-specific guidance, establish a new control-based revenue recognition model, change the basis for deciding when revenue is recognized over a time or point in time, provide new and more detailed guidance on specific topics and expand and improve disclosures about revenue. In addition, these amendments specify the accounting for some costs to obtain or fulfill a contract with a customer. The amendments are effective for annual and interim periods beginning after December 15, 2017, and must be retrospectively applied. The majority of the Company's income consists of net interest income on financial assets and financial liabilities, which is explicitly excluded from the scope of the amendments. The Company continues to evaluate the impact of the amendments on the components of noninterest income that have recurring revenue streams; however, the Company does not expect any recognition changes to have a significant impact to the Company's consolidated financial statements.

MARKETABLE SECURITIES (Tables)

MARKETABLE SECURITIES (Tables)	3 Months Ended
	Mar. 31, 2017
Investments, Debt and Equity Securities [Abstract]
Schedule of Amortized Cost and Fair Value of Available for Sale and Held to Maturity Securities	The following tables summarize the amortized cost and fair value of securities available for sale and securities held to maturity as of March 31, 2017 and December 31, 2016 and the corresponding amounts of gross unrealized gains and losses: March 31, 2017 Amortized Cost Gross Unrealized Gains Gross Estimated Fair Value Available for sale: Corporate bonds $ 25,223 $ 73 $ 123 $ 25,173 Municipal securities 7,817 — 539 7,278 Mortgage-backed securities 80,766 15 1,236 79,545 Collateralized mortgage obligations 102,688 236 457 102,467 Total available for sale $ 216,494 $ 324 $ 2,355 $ 214,463 Held to maturity: Municipal securities $ 148,520 $ 1,428 $ 2,621 $ 147,327 Mortgage-backed securities 26,900 312 191 27,021 Collateralized mortgage obligations 10,417 249 602 10,064 Total held to maturity $ 185,837 $ 1,989 $ 3,414 $ 184,412 December 31, 2016 Amortized Cost Gross Unrealized Gains Gross Estimated Fair Value Available for sale: Corporate bonds $ 25,254 $ 6 $ 377 $ 24,883 Municipal securities 7,841 — 622 7,219 Mortgage-backed securities 61,298 — 1,608 59,690 Collateralized mortgage obligations 65,789 10 666 65,133 Total available for sale $ 160,182 $ 16 $ 3,273 $ 156,925 Held to maturity: Municipal securities $ 149,420 $ 901 $ 3,889 $ 146,432 Mortgage-backed securities 28,450 318 290 28,478 Collateralized mortgage obligations 11,501 265 521 11,245 Total held to maturity $ 189,371 $ 1,484 $ 4,700 $ 186,155
Schedule of Securities with Gross Unrealized Losses	Information pertaining to securities with gross unrealized losses as of March 31, 2017 and December 31, 2016 aggregated by investment category and length of time that individual securities have been in a continuous unrealized loss position is detailed in the following tables: Less Than 12 Months 12 Months or Longer Total March 31, 2017 Gross Unrealized Losses Estimated Fair Value Gross Unrealized Losses Estimated Fair Value Gross Unrealized Losses Estimated Fair Value Available for sale: Corporate bonds $ (123 ) $ 12,508 $ — $ — $ (123 ) $ 12,508 Municipal securities (539 ) 7,278 — — (539 ) 7,278 Mortgage-backed securities (761 ) 62,344 (475 ) 14,870 (1,236 ) 77,214 Collateralized mortgage obligations (272 ) 42,026 (185 ) 8,645 (457 ) 50,671 Total available for sale $ (1,695 ) $ 124,156 $ (660 ) $ 23,515 $ (2,355 ) $ 147,671 Held to maturity: Municipal securities $ (2,414 ) $ 84,716 $ (207 ) $ 5,965 $ (2,621 ) $ 90,681 Mortgage-backed securities (191 ) 18,024 — — (191 ) 18,024 Collateralized mortgage obligations — — (602 ) 2,237 (602 ) 2,237 Total held to maturity $ (2,605 ) $ 102,740 $ (809 ) $ 8,202 $ (3,414 ) $ 110,942 Less Than 12 Months 12 Months or Longer Total December 31, 2016 Gross Unrealized Losses Estimated Fair Value Gross Unrealized Losses Estimated Fair Value Gross Unrealized Losses Estimated Fair Value Available for sale: Corporate bonds $ (377 ) $ 22,529 $ — $ — $ (377 ) $ 22,529 Municipal securities (622 ) 7,219 — — (622 ) 7,219 Mortgage-backed securities (1,047 ) 44,420 (561 ) 15,270 (1,608 ) 59,690 Collateralized mortgage obligations (437 ) 55,435 (229 ) 9,049 (666 ) 64,484 Total available for sale $ (2,483 ) $ 129,603 $ (790 ) $ 24,319 $ (3,273 ) $ 153,922 Held to maturity: Municipal securities $ (3,889 ) $ 98,943 $ — $ — $ (3,889 ) $ 98,943 Mortgage-backed securities (290 ) 19,983 — — (290 ) 19,983 Collateralized mortgage obligations — — (521 ) 2,350 (521 ) 2,350 Total held to maturity $ (4,179 ) $ 118,926 $ (521 ) $ 2,350 $ (4,700 ) $ 121,276
Schedule of Proceeds from Sales of Securities	The proceeds from sales of securities and the associated gains and losses are listed below for: Three Months Ended March 31, 2017 2016 Proceeds $ — $ 23,620 Gross gains — 75 Gross losses — (38 )
Schedule of Sale of Held To Maturity Securities	Sale of securities held to maturity were as follows for: Three Months Ended March 31, 2017 2016 Proceeds from sales $ — $ 1,866 Amortized cost — 1,842 Gross realized gains — 24 Tax expense related to securities gains/losses — (7 )
Investments Classified by Contractual Maturity Date	The contractual maturities at March 31, 2017 of available for sale and held to maturity securities at carrying value and estimated fair value are shown below. The Company invests in mortgage-backed securities and collateralized mortgage obligations that have expected maturities that differ from their contractual maturities. These differences arise because borrowers and/or issuers may have the right to call or prepay their obligation with or without call or prepayment penalties. Available for Sale Held to Maturity Amortized Cost Estimated Fair Value Amortized Cost Estimated Fair Value Due within one year $ — $ — $ 1,050 $ 1,055 Due after one year through five years 7,444 7,478 5,577 5,722 Due after five years through ten years 17,779 17,695 40,910 41,560 Due after ten years 7,817 7,278 100,983 98,990 Mortgage-backed securities 80,766 79,545 26,900 27,021 Collateralized mortgage obligations 102,688 102,467 10,417 10,064 $ 216,494 $ 214,463 $ 185,837 $ 184,412

LOANS AND ALLOWANCE FOR LOAN 24

LOANS AND ALLOWANCE FOR LOAN LOSSES (Tables)	3 Months Ended
	Mar. 31, 2017
Receivables [Abstract]
Summary of Loan Portfolio by Type of Loan	The following table summarizes our loan portfolio by type of loan as of: March 31, 2017 December 31, 2016 Commercial and industrial $ 205,903 $ 223,997 Real estate: Construction and development 152,760 129,366 Commercial real estate 372,855 367,656 Farmland 62,130 62,362 1-4 family residential 360,873 362,952 Multi-family residential 23,943 26,079 Consumer 52,816 53,505 Agricultural 21,473 18,901 Overdrafts 390 317 Total loans 1,253,143 1,245,135 Less: Allowance for loan losses 11,928 11,484 Total net loans $ 1,241,215 $ 1,233,651
Schedule of Allowance for Loan Losses Activity	The following table presents the activity in the allowance for loan losses and the recorded investment in loans by portfolio segment and based on impairment method for the three months ended March 31, 2017 , for the year ended December 31, 2016 and for the three months ended March 31, 2016 : For the three months ended March 31, 2017 Commercial Construction Commercial Farmland 1-4 family Multi-family Consumer Agricultural Overdrafts Total Allowance for loan losses: Beginning balance $ 1,592 $ 1,161 $ 3,264 $ 482 $ 3,960 $ 281 $ 585 $ 153 $ 6 $ 11,484 Provision for loan losses 177 188 123 (10 ) (72 ) (53 ) 280 2 15 650 Loans charged-off (6 ) — — — (118 ) — (89 ) — (35 ) (248 ) Recoveries — — — — — — 22 — 20 42 Ending balance $ 1,763 $ 1,349 $ 3,387 $ 472 $ 3,770 $ 228 $ 798 $ 155 $ 6 $ 11,928 Allowance ending balance: Individually evaluated for impairment $ 129 $ — $ 31 $ 41 $ 40 $ — $ — $ — $ — $ 241 Collectively evaluated for impairment 1,634 1,349 3,356 431 3,730 228 798 155 6 11,687 Loans: Individually evaluated for impairment 919 — 6,411 170 1,769 247 34 612 — 10,162 Collectively evaluated for impairment 204,984 152,760 366,444 61,960 359,104 23,696 52,782 20,861 390 1,242,981 Ending balance $ 205,903 $ 152,760 $ 372,855 $ 62,130 $ 360,873 $ 23,943 $ 52,816 $ 21,473 $ 390 $ 1,253,143 For the year ended December 31, 2016 Commercial Construction Commercial Farmland 1-4 family Multi-family Consumer Agricultural Overdrafts Total Allowance for loan losses: Beginning balance $ 1,878 $ 1,004 $ 2,106 $ 400 $ 2,839 $ 325 $ 562 $ 138 $ 11 $ 9,263 Provision for loan losses 910 162 1,158 82 1,117 (44 ) 171 15 69 3,640 Loans charged-off (1,213 ) (9 ) — — (71 ) — (269 ) — (200 ) (1,762 ) Recoveries 17 4 — — 75 — 121 — 126 343 Ending balance $ 1,592 $ 1,161 $ 3,264 $ 482 $ 3,960 $ 281 $ 585 $ 153 $ 6 $ 11,484 Allowance ending balance: Individually evaluated for impairment $ 64 $ — $ — $ 47 $ 108 $ — $ 34 $ — $ — $ 253 Collectively evaluated for impairment 1,528 1,161 3,264 435 3,852 281 551 153 6 11,231 Loans: Individually evaluated for impairment 231 1,825 1,196 258 2,588 5 200 15 — 6,318 Collectively evaluated for impairment 223,766 127,541 366,460 62,104 360,364 26,074 53,305 18,886 317 1,238,817 Ending balance $ 223,997 $ 129,366 $ 367,656 $ 62,362 $ 362,952 $ 26,079 $ 53,505 $ 18,901 $ 317 $ 1,245,135 For the three months ended March 31, 2016 Commercial Construction Commercial Farmland 1-4 family Multi-family Consumer Agricultural Overdrafts Total Allowance for loan losses: Beginning balance $ 1,878 $ 1,004 $ 2,106 $ 400 $ 2,839 $ 325 $ 562 $ 138 $ 11 $ 9,263 Provision for loan losses (504 ) (200 ) 145 (50 ) 1,115 13 (83 ) (12 ) 26 450 Loans charged-off — — — — (14 ) — (51 ) — (39 ) (104 ) Recoveries 11 4 — — — — 18 — 23 56 Ending balance $ 1,385 $ 808 $ 2,251 $ 350 $ 3,940 $ 338 $ 446 $ 126 $ 21 $ 9,665 Allowance ending balance: Individually evaluated for impairment $ 288 $ — $ — $ 47 $ 92 $ — $ 84 $ — $ — $ 511 Collectively evaluated for impairment 1,097 808 2,251 303 3,848 338 362 126 21 9,154 Loans: Individually evaluated for impairment 3,270 39 128 283 2,038 3 235 — — 5,996 Collectively evaluated for impairment 213,659 92,792 336,871 54,038 332,385 34,652 51,317 19,808 546 1,136,068 Ending balance $ 216,929 $ 92,831 $ 336,999 $ 54,321 $ 334,423 $ 34,655 $ 51,552 $ 19,808 $ 546 $ 1,142,064
Summary of Credit Exposure by Internally Assigned Grade	The following tables summarize the credit exposure in the consumer and commercial loan portfolios as of: March 31, 2017 Commercial and industrial Construction and development Commercial real estate Farmland 1-4 family residential Multi-family residential Consumer Agricultural Total Grade: Pass $ 200,851 $ 152,760 $ 365,789 $ 61,503 $ 354,074 $ 23,696 $ 52,308 $ 19,802 $ 1,230,783 Special mention 4,025 — 1,287 457 3,011 — 440 972 10,192 Substandard 1,027 — 5,701 170 3,745 247 397 699 11,986 Doubtful — — 78 — 43 — 61 — 182 Total $ 205,903 $ 152,760 $ 372,855 $ 62,130 $ 360,873 $ 23,943 $ 53,206 $ 21,473 $ 1,253,143 December 31, 2016 Commercial and industrial Construction and development Commercial real estate Farmland 1-4 family residential Multi-family residential Consumer Agricultural Total Grade: Pass $ 218,975 $ 127,537 $ 360,264 $ 61,713 $ 353,483 $ 25,871 $ 52,648 $ 17,965 $ 1,218,456 Special mention 4,299 4 1,927 248 4,311 — 524 478 11,791 Substandard 706 1,825 5,465 401 5,121 208 568 458 14,752 Doubtful 17 — — — 37 — 82 — 136 Total $ 223,997 $ 129,366 $ 367,656 $ 62,362 $ 362,952 $ 26,079 $ 53,822 $ 18,901 $ 1,245,135
Summary of Payment Status of Loans	The following tables summarize the payment status of loans in the Company’s total loan portfolio, including an aging of delinquent loans, loans 90 days or more past due continuing to accrue interest and loans classified as nonperforming as of: March 31, 2017 30 to 59 Days Past Due 60 to 89 Days Past Due 90 Days and Greater Past Due Total Past Due Current Total Loans Recorded Investment > 90 Days and Accruing Commercial and industrial 460 181 30 671 205,232 205,903 — Real estate: Construction and development 60 — — 60 152,700 152,760 — Commercial real estate 1,225 41 136 1,402 371,453 372,855 — Farmland 114 — — 114 62,016 62,130 — 1-4 family residential 3,867 323 1,183 5,373 355,500 360,873 — Multi-family residential 49 198 — 247 23,696 23,943 — Consumer 610 95 80 785 52,031 52,816 — Agricultural 188 14 14 216 21,257 21,473 — Overdrafts — — — — 390 390 — Total 6,573 852 1,443 8,868 1,244,275 1,253,143 — December 31, 2016 30 to 59 Days Past Due 60 to 89 Days Past Due 90 Days and Greater Past Due Total Past Due Current Total Recorded Investment > 90 Days and Accruing Commercial and industrial 941 105 25 1,071 222,926 223,997 — Real estate: Construction and development 73 — 1,825 1,898 127,468 129,366 — Commercial real estate 1,629 32 134 1,795 365,861 367,656 — Farmland 100 26 7 133 62,229 62,362 — 1-4 family residential 3,724 803 1,041 5,568 357,384 362,952 — Multi-family residential 207 49 — 256 25,823 26,079 — Consumer 613 205 87 905 52,600 53,505 — Agricultural 59 — 15 74 18,827 18,901 — Overdrafts — — — — 317 317 — Total 7,346 1,220 3,134 11,700 1,233,435 1,245,135 —
Schedule of Nonaccrual Loans	The following table presents information regarding nonaccrual loans as of: March 31, 2017 December 31, 2016 Commercial and industrial 517 82 Real estate: Construction and development — 1,825 Commercial real estate 136 415 Farmland 163 176 1-4 family residential 1,772 1,699 Multi-family residential — 5 Consumer 165 192 Agricultural 313 15 Total 3,066 4,409
Summary of Troubled Debt Restructuring	Three Months Ended March 31, 2016 Number of Contracts Pre-Modification Outstanding Recorded Investment Post-Modification Outstanding Recorded Investment Troubled Debt Restructurings: Consumer 3 23 23 Total 3 23 23 The following tables present loans by class modified as TDRs that occurred during the three months ended March 31, 2017 and 2016 : Three Months Ended March 31, 2017 Number of Contracts Pre-Modification Outstanding Recorded Investment Post-Modification Outstanding Recorded Investment Troubled Debt Restructurings: Commercial and industrial 1 34 34 1-4 family residential 1 11 11 Total 2 45 45 The outstanding balances of TDRs are shown below: March 31, 2017 December 31, 2016 Nonaccrual TDRs 42 90 Performing TDRs 330 415 Total 372 505 Specific reserves on TDRs 4 4
Summary of Impaired Loans	The following table presents information about the Company’s impaired loans as of and for the three months ended : March 31, 2017 Recorded Unpaid Related Average Interest With no related allowance recorded: Commercial and industrial $ 373 $ 373 $ — $ 159 $ 5 Real estate: Construction and development — — — 1,217 — Commercial real estate 5,893 5,893 — 4,936 73 Farmland 7 7 — 65 — 1-4 family residential 1,315 1,315 — 1,675 18 Multi-family residential 247 247 — 102 4 Consumer 34 34 — 105 1 Agricultural 612 612 — 214 13 Subtotal 8,481 8,481 — 8,473 114 With allowance recorded: Commercial and industrial 546 546 129 624 10 Real estate: Commercial real estate 518 518 31 251 3 Farmland 163 163 41 163 — 1-4 family residential 454 454 40 609 5 Consumer — — — 100 Subtotal 1,681 1,681 241 1,747 18 Total $ 10,162 $ 10,162 $ 241 $ 10,220 $ 132 The following table presents information about the Company’s impaired loans as of and for the year ended: December 31, 2016 Recorded Investment Unpaid Principal Balance Related Allowance Average Recorded Investment Interest Income Recognized With no related allowance recorded: Commercial and industrial $ 28 $ 28 $ — $ 809 $ 3 Real estate: Construction and development 1,825 1,825 — 172 84 Commercial real estate 1,196 1,196 — 871 47 Farmland 89 89 — 109 5 1-4 family residential 1,799 1,799 — 1,575 106 Multi-family residential 5 5 — 2 1 Consumer 105 105 — 89 12 Agricultural 15 15 — 68 2 Subtotal 5,062 5,062 — 3,695 260 With allowance recorded: Commercial and industrial 203 203 64 3,153 4 Real estate: Farmland 169 169 47 169 1 1-4 family residential 789 789 108 639 44 Consumer 95 95 34 155 8 Agricultural — — — 2 — Subtotal 1,256 1,256 253 4,118 57 Total $ 6,318 $ 6,318 $ 253 $ 7,813 $ 317

SUBORDINATED DEBENTURES (Tables

SUBORDINATED DEBENTURES (Tables)	3 Months Ended
	Mar. 31, 2017
Debt Disclosure [Abstract]
Schedule of Subordinated Debentures and Other Debentures	Debentures II Debentures III DCB Debentures I Original amount $ 3,093 $ 2,062 $ 5,155 Maturity date October 30, 2032 October 1, 2036 June 15, 2037 Interest due Quarterly Quarterly Quarterly Subordinated debentures are made up of the following as of: March 31, 2017 December 31, 2016 Debentures II $ 3,093 $ 3,093 Debentures III 2,062 2,062 DCB Debentures I 5,155 5,155 Other Debentures 9,000 9,000 $ 19,310 $ 19,310
Schedule of Trusts	Trust II Trust III DCB Trust I Formation date October 30, 2002 July 25, 2006 March 29, 2007 Capital trust pass-through securities Number of shares 3,000 2,000 5,000 Original liquidation value $ 3,000 $ 2,000 $ 5,000 Common securities liquidation value 93 62 155

STOCK OPTIONS (Tables)

STOCK OPTIONS (Tables)	3 Months Ended
	Mar. 31, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Schedule of Stock Option Activity	A summary of activity in the Plan during the three months ended March 31, 2017 and 2016 follows: Three Months Ended March 31, 2017 Number of Shares Weighted-Average Exercise Price Weighted-Average Remaining Contractual Life in Years Aggregate Intrinsic Value Outstanding at beginning of year 340,377 $ 23.43 7.34 $ 194 Granted 9,000 26.00 9.96 — Exercised (2,010 ) 11.94 3.08 28 Forfeited (1,000 ) 24.00 5.55 2 Balance, March 31, 2017 346,367 $ 23.56 7.19 $ 844 Exercisable at end of period 92,667 $ 22.91 6.46 $ 287 Three Months Ended March 31, 2016 Number of Shares Weighted-Average Exercise Price Weighted-Average Remaining Contractual Life in Years Aggregate Intrinsic Value Outstanding at beginning of year 314,391 $ 23.28 8.00 $ 225 Granted 21,000 23.00 8.79 21 Forfeited (10,400 ) 23.23 7.74 8 Balance, March 31, 2016 324,991 $ 23.27 7.86 $ 238 Exercisable at end of period 47,191 $ 20.83 6.51 $ 149
Schedule of Nonvested Stock Option Activity	A summary of nonvested activity in the Plan during the three months ended March 31, 2017 and 2016 follows: Three Months Ended March 31, 2017 Number of Shares Weighted-Average Exercise Price Weighted-Average Remaining Contractual Life in Years Aggregate Intrinsic Value Outstanding at beginning of year 250,700 $ 23.73 7.65 $ 69 Granted 9,000 26.00 9.96 — Vested (6,000 ) 23.90 9.15 13 Balance, March 31, 2017 253,700 $ 23.80 7.46 $ 557 Three Months Ended March 31, 2016 Number of Shares Weighted-Average Exercise Price Weighted-Average Remaining Contractual Life in Years Aggregate Intrinsic Value Outstanding at beginning of year 267,200 $ 23.72 8.22 $ — Granted 21,000 23.00 8.79 21 Vested (10,400 ) 23.23 7.47 8 Balance, March 31, 2016 277,800 $ 23.68 8.09 $ 89
Plan Information	Information related to the Plan is as follows for the three months ended : March 31, 2017 Intrinsic value of options exercised $ 28 Cash received from options exercised 24 Tax benefit realized from options exercised — Weighted average fair value of options granted 4.30

INCOME TAXES (Tables)

INCOME TAXES (Tables)	3 Months Ended
	Mar. 31, 2017
Income Tax Disclosure [Abstract]
Schedule of Income Tax Expense and Effective Tax Rate	Income tax expenses were as follows for: Three Months Ended March 31, 2017 2016 Income tax expense for the period $ 1,312 $ 1,090 Effective tax rate 27.19 % 28.93 %

DERIVATIVE FINANCIAL INSTRUME28

DERIVATIVE FINANCIAL INSTRUMENTS (Tables)	3 Months Ended
	Mar. 31, 2017
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Interest Rates Swap Agreements	The information pertaining to outstanding interest rate swap agreements used to hedge floating rate debentures was as follows as of: March 31, 2017: Notional Amount Pay Rate Receive Rate Effective Date Maturity in Years Unrealized Losses $ 2,000 5.979 % 3 month LIBOR plus 1.67% October 1, 2016 9.01 $ 329 $ 3,000 7.505 % 3 month LIBOR plus 3.35% October 30, 2012 5.59 $ 331 December 31, 2016: Notional Amount Pay Rate Receive Rate Effective Date Maturity in Years Unrealized Losses $ 2,000 5.979 % 3 month LIBOR plus 1.67% October 1, 2016 9.25 $ 342 $ 3,000 7.505 % 3 month LIBOR plus 3.35% October 30, 2012 5.83 $ 353

COMMITMENTS AND CONTINGENCIES (

COMMITMENTS AND CONTINGENCIES (Tables)	3 Months Ended
	Mar. 31, 2017
Commitments and Contingencies Disclosure [Abstract]
Schedule of Commitments and Letters of Credit Outstanding	Commitments and letters of credit outstanding were as follows as of: Contract or Notional Amount March 31, 2017 December 31, 2016 Commitments to extend credit $ 350,323 $ 297,607 Letters of credit 9,113 8,879

REGULATORY MATTERS (Tables)

REGULATORY MATTERS (Tables)	3 Months Ended
	Mar. 31, 2017
Banking and Thrift [Abstract]
Comparison of the Company's and Bank's Actual Capital Amounts and Ratios to Required Capital Amounts and Ratios	A comparison of the Company’s and Bank’s actual capital amounts and ratios to required capital amounts and ratios are presented in the following tables as of: Actual Minimum Required For Capital Adequacy Purposes To Be Well Capitalized Under Prompt Corrective Action Provisions Amount Ratio Amount Ratio Amount Ratio March 31, 2017 Total capital to risk-weighted assets: Consolidated $ 152,967 10.84 % $ 112,877 8.00 % n/a Bank 177,589 12.60 % 112,778 8.00 % $ 140,973 10.00 % Tier 1 capital to risk-weighted assets: Consolidated 141,039 10.00 % 84,658 6.00 % n/a Bank 165,661 11.75 % 84,584 6.00 % 112,778 8.00 % Tier 1 capital to average assets: Consolidated 141,039 7.66 % 73,640 4.00 % n/a Bank 165,661 9.01 % 73,572 4.00 % 91,965 5.00 % Common equity tier 1 risk-based capital: Consolidated 130,729 9.27 % 63,494 4.50 % n/a Bank 165,661 11.75 % 63,438 4.50 % 91,632 6.50 % Actual Minimum Required For Capital Adequacy Purposes To Be Well Capitalized Under Prompt Corrective Action Provisions Amount Ratio Amount Ratio Amount Ratio December 31, 2016 Total capital to risk-weighted assets: Consolidated $ 149,468 10.86 % $ 110,083 8.00 % n/a Bank 173,528 12.63 % 109,947 8.00 % $ 137,434 10.00 % Tier 1 capital to risk-weighted assets: Consolidated 137,984 10.03 % 82,562 6.00 % n/a Bank 162,044 11.79 % 82,460 6.00 % 109,947 8.00 % Tier 1 capital to average assets: Consolidated 137,984 7.71 % 71,560 4.00 % n/a Bank 162,044 9.06 % 71,505 4.00 % 89,381 5.00 % Common equity tier 1 risk-based capital: Consolidated 127,674 9.28 % 61,922 4.50 % n/a Bank 162,044 11.79 % 61,845 4.50 % 89,332 6.50 %

FAIR VALUE (Tables)

FAIR VALUE (Tables)	3 Months Ended
	Mar. 31, 2017
Fair Value Disclosures [Abstract]
Schedule of Financial Assets (Liabilities) Measured at Fair Value	The following tables summarize quantitative disclosures about the fair value measurements for each category of financial assets (liabilities) carried at fair value: As of March 31, 2017 Fair Value Quoted Prices in Active Markets for Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) Significant Other Unobservable Inputs (Level 3) Assets (liabilities) at fair value on a recurring basis: Available for sale securities Mortgage-backed securities $ 79,545 $ — $ 79,545 $ — Collateralized mortgage obligations 102,467 — 102,467 — Municipal securities 7,278 — 7,278 — Corporate bonds 25,173 — 25,173 — Derivative instruments (661 ) — (661 ) — Assets at fair value on a nonrecurring basis: Impaired loans 9,921 — — 9,921 Other real estate owned 1,637 — — 1,637 As of December 31, 2016 Fair Value Quoted Prices in Active Markets for Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) Significant Other Unobservable Inputs (Level 3) Assets (liabilities) at fair value on a recurring basis: Available for sale securities Mortgage-backed securities $ 59,690 $ — $ 59,690 $ — Collateralized mortgage obligations 65,133 — 65,133 — Corporate bonds 24,883 — 24,883 — U.S. treasury securities — — — — Derivative instruments (695 ) — (695 ) — Assets at fair value on a nonrecurring basis: Impaired loans 6,065 — — 6,065 Other real estate owned 1,692 — — 1,692
Schedule of Foreclosed Assets Measured at Fair Value	The following table presents foreclosed assets that were remeasured and recorded at fair value as of: March 31, 2017 December 31, 2016 March 31, 2016 Foreclosed assets remeasured at initial recognition: Carrying value of foreclosed assets prior to remeasurement $ 87 $ 78 $ 134 Charge-offs recognized in the allowance for loan losses (78 ) (11 ) (14 ) Fair value of foreclosed assets remeasured at initial recognition $ 9 $ 67 $ 120 Foreclosed assets remeasured subsequent to initial recognition: Carrying value of foreclosed assets prior to remeasurement $ — $ 170 $ — Write-downs included in collection and other real estate owned expense — (69 ) — Fair value of foreclosed assets remeasured subsequent to initial recognition $ — $ 101 $ —
Schedule of Quantitative Information About Nonrecurring Level 3 Fair Value Measurements	The following tables present quantitative information about nonrecurring Level 3 fair value measurements as of: Fair Value Valuation Technique(s) Unobservable Input(s) Range (Weighted Average) March 31, 2017 Impaired loans $ 9,921 Fair value of collateral - sales comparison approach Selling costs or other normal adjustments: Real estate Equipment 10%-20% (16%) 10%-20% (14%) Other real estate owned $ 1,637 Appraisal value of collateral Selling costs or other normal adjustments 10%-20% (16%) Fair Value Valuation Technique(s) Unobservable Input(s) Range (Weighted Average) December 31, 2016 Impaired loans $ 6,065 Fair value of collateral - sales comparison approach Selling costs or other normal adjustments: Real estate Equipment 10%-20% (16%) 40%-50% (42%) Other real estate owned $ 1,692 Appraisal value of collateral Selling costs or other normal adjustments 10%-20% (16%)
Schedule of Carrying Amounts And Estimated Fair Values of Financial Instruments	The carrying amounts and estimated fair values of financial instruments, not previously in this note, as of March 31, 2017 and December 31, 2016 are as follows: Fair value measurements as of Carrying Amount Level 1 Inputs Level 2 Inputs Level 3 Inputs Total Fair Value Financial assets: Cash, due from banks, federal funds sold and interest-bearing deposits $ 143,757 $ 115,751 $ 28,006 $ — $ 143,757 Marketable securities held to maturity 185,837 — 184,412 — 184,412 Loans, net 1,241,215 — — 1,246,011 1,246,011 Accrued interest receivable 6,304 — 6,304 — 6,304 Nonmarketable equity securities 7,285 — 7,285 — 7,285 Cash surrender value of life insurance 17,922 — 17,922 — 17,922 Financial liabilities: Deposits $ 1,671,171 $ 1,335,456 $ 336,371 $ — $ 1,671,827 Securities sold under repurchase agreements 12,663 — 12,663 — 12,663 Accrued interest payable 1,010 — 1,010 — 1,010 Other debt 18,929 — 18,929 — 18,929 Federal Home Loan Bank advances 25,165 — 25,163 — 25,163 Subordinated debentures 19,310 — 16,852 — 16,852 Fair value measurements as of Carrying Amount Level 1 Inputs Level 2 Inputs Level 3 Inputs Total Fair Value Financial assets: Cash, due from banks, federal funds sold and interest-bearing deposits $ 127,543 $ 100,205 $ 27,338 $ — $ 127,543 Marketable securities held to maturity 189,371 — 186,155 — 186,155 Loans, net 1,233,651 — — 1,235,306 1,235,306 Accrued interest receivable 7,419 — 7,419 — 7,419 Nonmarketable equity securities 10,500 — 10,500 — 10,500 Cash surrender value of life insurance 17,804 — 17,804 — 17,804 Financial liabilities: Deposits $ 1,576,791 $ 1,234,875 $ 342,615 $ — $ 1,577,490 Securities sold under repurchase agreements 10,859 — 10,859 — 10,859 Accrued interest payable 889 — 889 — 889 Other debt 18,286 — 18,286 — 18,286 Federal Home Loan Bank advances 55,170 — 55,160 — 55,160 Subordinated debentures 19,310 — 16,809 — 16,809

EARNINGS PER SHARE (Tables)

EARNINGS PER SHARE (Tables)	3 Months Ended
	Mar. 31, 2017
Earnings Per Share [Abstract]
Schedule of Basic and Diluted Earnings Per Share	The computations of basic and diluted earnings per share for the Company were as follows as of: March 31, 2017 March 31, 2016 Numerator: Net earnings (basic) $ 3,516 $ 2,677 Net earnings (diluted) $ 3,516 $ 2,677 Denominator: Weighted-average shares outstanding (basic) 8,751,945 8,968,052 Effect of dilutive securities: Common stock equivalent shares from stock options 32,465 9,914 Weighted-average shares outstanding (diluted) 8,784,410 8,977,966 Net earnings per share Basic $ 0.40 $ 0.30 Diluted $ 0.40 $ 0.30

SUMMARY OF SIGNIFICANT ACCOUN33

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details) $ / shares in Units, $ in Thousands	1 Months Ended
	May 31, 2017USD ($)$ / sharesshares	Mar. 31, 2017subsidary$ / shares	Dec. 31, 2016$ / shares
Subsequent Event [Line Items]
Par value (in dollars per share) | $ / shares		$ 1	$ 1
Subsequent Event
Subsequent Event [Line Items]
Par value (in dollars per share) | $ / shares	$ 1
Repayment of other debt	$ 19,900
Repayment of subordinated debentures	5,000
Contribution to subsidiary	$ 15,000
Subsequent Event | IPO
Subsequent Event [Line Items]
Initial public offering common stock issued (in shares) | shares	2,300,000
Purchase price (in dollars per share) | $ / shares	$ 27
Gross proceeds from initial public offering	$ 62,100
Net proceeds from initial public offering	$ 57,600
The Bank
Subsequent Event [Line Items]
Number of wholly-owned non-bank subsidiaries | subsidary		5

ACQUISITIONS - Narrative (Detai

ACQUISITIONS - Narrative (Details) - USD ($) $ in Thousands	Aug. 06, 2016	Mar. 31, 2017	Dec. 31, 2016
Business Acquisition [Line Items]
Goodwill		$ 18,742	$ 18,742
Denton, Texas Branch Location
Business Acquisition [Line Items]
Assets acquired	$ 4,659
Liabilities assumed	4,659
Bank premises acquired	2,075
Cash acquired	2,399
Core deposit intangibles acquired	42
Goodwill	141
Loans acquired	2
Non-interest bearing deposits assumed	581
Interest bearing deposits assumed	4,047
Other liabilities assumed	30
Consideration paid	66
Goodwill expected to be deducted	$ 141

MARKETABLE SECURITIES - Schedul

MARKETABLE SECURITIES - Schedule of Amortized Cost and Fair Value of Securities (Details) - USD ($) $ in Thousands	Mar. 31, 2017	Dec. 31, 2016
Available for sale:
Amortized Cost	$ 216,494	$ 160,182
Gross Unrealized Gains	324	16
Gross Unrealized Losses	2,355	3,273
Estimated Fair Value	214,463	156,925
Held to maturity:
Amortized Cost	185,837	189,371
Gross Unrealized Gains	1,989	1,484
Gross Unrealized Losses	3,414	4,700
Estimated Fair Value	184,412	186,155
Corporate bonds
Available for sale:
Amortized Cost	25,223	25,254
Gross Unrealized Gains	73	6
Gross Unrealized Losses	123	377
Estimated Fair Value	25,173	24,883
Municipal securities
Available for sale:
Amortized Cost	7,817	7,841
Gross Unrealized Gains	0	0
Gross Unrealized Losses	539	622
Estimated Fair Value	7,278	7,219
Mortgage-backed securities
Available for sale:
Amortized Cost	80,766	61,298
Gross Unrealized Gains	15	0
Gross Unrealized Losses	1,236	1,608
Estimated Fair Value	79,545	59,690
Collateralized mortgage obligations
Available for sale:
Amortized Cost	102,688	65,789
Gross Unrealized Gains	236	10
Gross Unrealized Losses	457	666
Estimated Fair Value	102,467	65,133
Municipal securities
Held to maturity:
Amortized Cost	148,520	149,420
Gross Unrealized Gains	1,428	901
Gross Unrealized Losses	2,621	3,889
Estimated Fair Value	147,327	146,432
Mortgage-backed securities
Held to maturity:
Amortized Cost	26,900	28,450
Gross Unrealized Gains	312	318
Gross Unrealized Losses	191	290
Estimated Fair Value	27,021	28,478
Collateralized mortgage obligations
Held to maturity:
Amortized Cost	10,417	11,501
Gross Unrealized Gains	249	265
Gross Unrealized Losses	602	521
Estimated Fair Value	$ 10,064	$ 11,245

MARKETABLE SECURITIES - Narrati

MARKETABLE SECURITIES - Narrative (Details)	3 Months Ended
	Mar. 31, 2016security	Mar. 31, 2017USD ($)position	Dec. 31, 2016USD ($)position
Schedule of Available-for-sale Securities [Line Items]
Securities held to maturity		$ 185,837,000	$ 189,371,000
Unrealized losses		3,414,000	4,700,000
Other than temporary impairment losses on debt securities related to credit losses		$ 0	$ 0
Number of positions in an unrealized loss position | position		152	177
Fair value of securities pledged as collateral		$ 264,248,000	$ 259,499,000
Number of held-to-maturity securities sold | security	3
Non-Agency Collateralized Mortgage Obligations
Schedule of Available-for-sale Securities [Line Items]
Securities held to maturity		1,493,000
Unrealized losses		$ 602,000

MARKETABLE SECURITIES - Securit

MARKETABLE SECURITIES - Securities in Continuous Loss Position (Details) - USD ($) $ in Thousands	Mar. 31, 2017	Dec. 31, 2016
Gross Unrealized Losses
Less Than 12 Months	$ (1,695)	$ (2,483)
12 Months or Longer	(660)	(790)
Total	(2,355)	(3,273)
Estimated Fair Value
Less Than 12 Months	124,156	129,603
12 Months or Longer	23,515	24,319
Total	147,671	153,922
Gross Unrealized Losses
Less Than 12 Months	(2,605)	(4,179)
12 Months or Longer	(809)	(521)
Total	(3,414)	(4,700)
Estimated Fair Value
Less Than 12 Months	102,740	118,926
12 Months or Longer	8,202	2,350
Total	110,942	121,276
Corporate bonds
Gross Unrealized Losses
Less Than 12 Months	(123)	(377)
12 Months or Longer	0	0
Total	(123)	(377)
Estimated Fair Value
Less Than 12 Months	12,508	22,529
12 Months or Longer	0	0
Total	12,508	22,529
Municipal securities
Gross Unrealized Losses
Less Than 12 Months	(539)	(622)
12 Months or Longer	0	0
Total	(539)	(622)
Estimated Fair Value
Less Than 12 Months	7,278	7,219
12 Months or Longer	0	0
Total	7,278	7,219
Mortgage-backed securities
Gross Unrealized Losses
Less Than 12 Months	(761)	(1,047)
12 Months or Longer	(475)	(561)
Total	(1,236)	(1,608)
Estimated Fair Value
Less Than 12 Months	62,344	44,420
12 Months or Longer	14,870	15,270
Total	77,214	59,690
Collateralized mortgage obligations
Gross Unrealized Losses
Less Than 12 Months	(272)	(437)
12 Months or Longer	(185)	(229)
Total	(457)	(666)
Estimated Fair Value
Less Than 12 Months	42,026	55,435
12 Months or Longer	8,645	9,049
Total	50,671	64,484
Municipal securities
Gross Unrealized Losses
Less Than 12 Months	(2,414)	(3,889)
12 Months or Longer	(207)	0
Total	(2,621)	(3,889)
Estimated Fair Value
Less Than 12 Months	84,716	98,943
12 Months or Longer	5,965	0
Total	90,681	98,943
Mortgage-backed securities
Gross Unrealized Losses
Less Than 12 Months	(191)	(290)
12 Months or Longer	0	0
Total	(191)	(290)
Estimated Fair Value
Less Than 12 Months	18,024	19,983
12 Months or Longer	0	0
Total	18,024	19,983
Collateralized mortgage obligations
Gross Unrealized Losses
Less Than 12 Months	0	0
12 Months or Longer	(602)	(521)
Total	(602)	(521)
Estimated Fair Value
Less Than 12 Months	0	0
12 Months or Longer	2,237	2,350
Total	$ 2,237	$ 2,350

MARKETABLE SECURITIES - Sale of

MARKETABLE SECURITIES - Sale of Securities (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Sale of Marketable Securities [Abstract]
Proceeds	$ 0	$ 23,620
Gross gains	0	75
Gross losses	0	(38)
Held-to-maturity Securities, Sales, Excluding Other than Temporary Impairments [Abstract]
Proceeds from sales	0	1,866
Amortized cost	0	1,842
Gross realized gains	0	24
Tax expense related to securities gains/losses	$ 0	$ (7)

MARKETABLE SECURITIES - Contrac

MARKETABLE SECURITIES - Contractual Maturities of Securities (Details) - USD ($) $ in Thousands	Mar. 31, 2017	Dec. 31, 2016
Amortized Cost
Due within one year	$ 0
Due after one year through five years	7,444
Due after five years through ten years	17,779
Due after ten years	7,817
Available-for-sale debt securities, amortized cost basis	216,494
Estimated Fair Value
Due within one year	0
Due after one year through five years	7,478
Due after five years through ten years	17,695
Due after ten years	7,278
Available-for-sale debt securities, estimated fair value	214,463
Amortized Cost
Due within one year	1,050
Due after one year through five years	5,577
Due after five years through ten years	40,910
Due after ten years	100,983
Amortized Cost	185,837	$ 189,371
Estimated Fair Value
Due within one year	1,055
Due after one year through five years	5,722
Due after five years through ten years	41,560
Due after ten years	98,990
Held-to-maturity securities, estimated fair value	184,412	$ 186,155
Mortgage-backed securities
Amortized Cost
Available-for-sale securities without single maturity date	80,766
Estimated Fair Value
Available-for-sale securities without single maturity date	79,545
Amortized Cost
Held-to-maturity securities, without single maturity date	26,900
Estimated Fair Value
Held-to-maturity securities, without single maturity date	27,021
Collateralized mortgage obligations
Amortized Cost
Available-for-sale securities without single maturity date	102,688
Estimated Fair Value
Available-for-sale securities without single maturity date	102,467
Amortized Cost
Held-to-maturity securities, without single maturity date	10,417
Estimated Fair Value
Held-to-maturity securities, without single maturity date	$ 10,064

LOANS AND ALLOWANCE FOR LOAN 40

LOANS AND ALLOWANCE FOR LOAN LOSSES - Summary of Loan Portfolio by Type of Loan (Details) - USD ($) $ in Thousands	Mar. 31, 2017	Dec. 31, 2016	Mar. 31, 2016	Dec. 31, 2015
Loans held for investment:
Total loans	$ 1,253,143	$ 1,245,135	$ 1,142,064
Less: Allowance for loan losses	11,928	11,484	9,665	$ 9,263
Total net loans	1,241,215	1,233,651
Unamortized loan costs, net of loan fees	1,055	1,210
Commercial and industrial
Loans held for investment:
Total loans	205,903	223,997	216,929
Less: Allowance for loan losses	1,763	1,592	1,385	1,878
Construction and development
Loans held for investment:
Total loans	152,760	129,366	92,831
Less: Allowance for loan losses	1,349	1,161	808	1,004
Commercial real estate
Loans held for investment:
Total loans	372,855	367,656	336,999
Less: Allowance for loan losses	3,387	3,264	2,251	2,106
Farmland
Loans held for investment:
Total loans	62,130	62,362	54,321
Less: Allowance for loan losses	472	482	350	400
1-4 family residential
Loans held for investment:
Total loans	360,873	362,952	334,423
Less: Allowance for loan losses	3,770	3,960	3,940	2,839
Multi-family residential
Loans held for investment:
Total loans	23,943	26,079	34,655
Less: Allowance for loan losses	228	281	338	325
Consumer
Loans held for investment:
Total loans	52,816	53,505	51,552
Less: Allowance for loan losses	798	585	446	562
Agricultural
Loans held for investment:
Total loans	21,473	18,901	19,808
Less: Allowance for loan losses	155	153	126	138
Overdrafts
Loans held for investment:
Total loans	390	317	546
Less: Allowance for loan losses	$ 6	$ 6	$ 21	$ 11

LOANS AND ALLOWANCE FOR LOAN 41

LOANS AND ALLOWANCE FOR LOAN LOSSES - Schedule of Allowance for Loan Losses Activity (Details) - USD ($) $ in Thousands	3 Months Ended		12 Months Ended
	Mar. 31, 2017	Mar. 31, 2016	Dec. 31, 2016
Allowance for loan losses:
Beginning balance	$ 11,484	$ 9,263	$ 9,263
Provision for loan losses	650	450	3,640
Loans charged-off	(248)	(104)	(1,762)
Recoveries	42	56	343
Ending balance	11,928	9,665	11,484
Allowance ending balance:
Individually evaluated for impairment	241	511	253
Collectively evaluated for impairment	11,687	9,154	11,231
Loans:
Individually evaluated for impairment	10,162	5,996	6,318
Collectively evaluated for impairment	1,242,981	1,136,068	1,238,817
Ending balance	1,253,143	1,142,064	1,245,135
Commercial and industrial
Allowance for loan losses:
Beginning balance	1,592	1,878	1,878
Provision for loan losses	177	(504)	910
Loans charged-off	(6)	0	(1,213)
Recoveries	0	11	17
Ending balance	1,763	1,385	1,592
Allowance ending balance:
Individually evaluated for impairment	129	288	64
Collectively evaluated for impairment	1,634	1,097	1,528
Loans:
Individually evaluated for impairment	919	3,270	231
Collectively evaluated for impairment	204,984	213,659	223,766
Ending balance	205,903	216,929	223,997
Construction and development
Allowance for loan losses:
Beginning balance	1,161	1,004	1,004
Provision for loan losses	188	(200)	162
Loans charged-off	0	0	(9)
Recoveries	0	4	4
Ending balance	1,349	808	1,161
Allowance ending balance:
Individually evaluated for impairment	0	0	0
Collectively evaluated for impairment	1,349	808	1,161
Loans:
Individually evaluated for impairment	0	39	1,825
Collectively evaluated for impairment	152,760	92,792	127,541
Ending balance	152,760	92,831	129,366
Commercial real estate
Allowance for loan losses:
Beginning balance	3,264	2,106	2,106
Provision for loan losses	123	145	1,158
Loans charged-off	0	0	0
Recoveries	0	0	0
Ending balance	3,387	2,251	3,264
Allowance ending balance:
Individually evaluated for impairment	31	0	0
Collectively evaluated for impairment	3,356	2,251	3,264
Loans:
Individually evaluated for impairment	6,411	128	1,196
Collectively evaluated for impairment	366,444	336,871	366,460
Ending balance	372,855	336,999	367,656
Farmland
Allowance for loan losses:
Beginning balance	482	400	400
Provision for loan losses	(10)	(50)	82
Loans charged-off	0	0	0
Recoveries	0	0	0
Ending balance	472	350	482
Allowance ending balance:
Individually evaluated for impairment	41	47	47
Collectively evaluated for impairment	431	303	435
Loans:
Individually evaluated for impairment	170	283	258
Collectively evaluated for impairment	61,960	54,038	62,104
Ending balance	62,130	54,321	62,362
1-4 family residential
Allowance for loan losses:
Beginning balance	3,960	2,839	2,839
Provision for loan losses	(72)	1,115	1,117
Loans charged-off	(118)	(14)	(71)
Recoveries	0	0	75
Ending balance	3,770	3,940	3,960
Allowance ending balance:
Individually evaluated for impairment	40	92	108
Collectively evaluated for impairment	3,730	3,848	3,852
Loans:
Individually evaluated for impairment	1,769	2,038	2,588
Collectively evaluated for impairment	359,104	332,385	360,364
Ending balance	360,873	334,423	362,952
Multi-family residential
Allowance for loan losses:
Beginning balance	281	325	325
Provision for loan losses	(53)	13	(44)
Loans charged-off	0	0	0
Recoveries	0	0	0
Ending balance	228	338	281
Allowance ending balance:
Individually evaluated for impairment	0	0	0
Collectively evaluated for impairment	228	338	281
Loans:
Individually evaluated for impairment	247	3	5
Collectively evaluated for impairment	23,696	34,652	26,074
Ending balance	23,943	34,655	26,079
Consumer
Allowance for loan losses:
Beginning balance	585	562	562
Provision for loan losses	280	(83)	171
Loans charged-off	(89)	(51)	(269)
Recoveries	22	18	121
Ending balance	798	446	585
Allowance ending balance:
Individually evaluated for impairment	0	84	34
Collectively evaluated for impairment	798	362	551
Loans:
Individually evaluated for impairment	34	235	200
Collectively evaluated for impairment	52,782	51,317	53,305
Ending balance	52,816	51,552	53,505
Agricultural
Allowance for loan losses:
Beginning balance	153	138	138
Provision for loan losses	2	(12)	15
Loans charged-off	0	0	0
Recoveries	0	0	0
Ending balance	155	126	153
Allowance ending balance:
Individually evaluated for impairment	0	0	0
Collectively evaluated for impairment	155	126	153
Loans:
Individually evaluated for impairment	612	0	15
Collectively evaluated for impairment	20,861	19,808	18,886
Ending balance	21,473	19,808	18,901
Overdrafts
Allowance for loan losses:
Beginning balance	6	11	11
Provision for loan losses	15	26	69
Loans charged-off	(35)	(39)	(200)
Recoveries	20	23	126
Ending balance	6	21	6
Allowance ending balance:
Individually evaluated for impairment	0	0	0
Collectively evaluated for impairment	6	21	6
Loans:
Individually evaluated for impairment	0	0	0
Collectively evaluated for impairment	390	546	317
Ending balance	$ 390	$ 546	$ 317

LOANS AND ALLOWANCE FOR LOAN 42

LOANS AND ALLOWANCE FOR LOAN LOSSES - Summary of Credit Exposure (Details) - USD ($) $ in Thousands	Mar. 31, 2017	Dec. 31, 2016	Mar. 31, 2016
Financing Receivable, Recorded Investment [Line Items]
Total loans	$ 1,253,143	$ 1,245,135	$ 1,142,064
Pass
Financing Receivable, Recorded Investment [Line Items]
Total loans	1,230,783	1,218,456
Special mention
Financing Receivable, Recorded Investment [Line Items]
Total loans	10,192	11,791
Substandard
Financing Receivable, Recorded Investment [Line Items]
Total loans	11,986	14,752
Doubtful
Financing Receivable, Recorded Investment [Line Items]
Total loans	182	136
Commercial and industrial
Financing Receivable, Recorded Investment [Line Items]
Total loans	205,903	223,997	216,929
Commercial and industrial | Pass
Financing Receivable, Recorded Investment [Line Items]
Total loans	200,851	218,975
Commercial and industrial | Special mention
Financing Receivable, Recorded Investment [Line Items]
Total loans	4,025	4,299
Commercial and industrial | Substandard
Financing Receivable, Recorded Investment [Line Items]
Total loans	1,027	706
Commercial and industrial | Doubtful
Financing Receivable, Recorded Investment [Line Items]
Total loans	0	17
Construction and development
Financing Receivable, Recorded Investment [Line Items]
Total loans	152,760	129,366	92,831
Construction and development | Pass
Financing Receivable, Recorded Investment [Line Items]
Total loans	152,760	127,537
Construction and development | Special mention
Financing Receivable, Recorded Investment [Line Items]
Total loans	0	4
Construction and development | Substandard
Financing Receivable, Recorded Investment [Line Items]
Total loans	0	1,825
Construction and development | Doubtful
Financing Receivable, Recorded Investment [Line Items]
Total loans	0	0
Commercial real estate
Financing Receivable, Recorded Investment [Line Items]
Total loans	372,855	367,656	336,999
Commercial real estate | Pass
Financing Receivable, Recorded Investment [Line Items]
Total loans	365,789	360,264
Commercial real estate | Special mention
Financing Receivable, Recorded Investment [Line Items]
Total loans	1,287	1,927
Commercial real estate | Substandard
Financing Receivable, Recorded Investment [Line Items]
Total loans	5,701	5,465
Commercial real estate | Doubtful
Financing Receivable, Recorded Investment [Line Items]
Total loans	78	0
Farmland
Financing Receivable, Recorded Investment [Line Items]
Total loans	62,130	62,362	54,321
Farmland | Pass
Financing Receivable, Recorded Investment [Line Items]
Total loans	61,503	61,713
Farmland | Special mention
Financing Receivable, Recorded Investment [Line Items]
Total loans	457	248
Farmland | Substandard
Financing Receivable, Recorded Investment [Line Items]
Total loans	170	401
Farmland | Doubtful
Financing Receivable, Recorded Investment [Line Items]
Total loans	0	0
1-4 family residential
Financing Receivable, Recorded Investment [Line Items]
Total loans	360,873	362,952	334,423
1-4 family residential | Pass
Financing Receivable, Recorded Investment [Line Items]
Total loans	354,074	353,483
1-4 family residential | Special mention
Financing Receivable, Recorded Investment [Line Items]
Total loans	3,011	4,311
1-4 family residential | Substandard
Financing Receivable, Recorded Investment [Line Items]
Total loans	3,745	5,121
1-4 family residential | Doubtful
Financing Receivable, Recorded Investment [Line Items]
Total loans	43	37
Multi-family residential
Financing Receivable, Recorded Investment [Line Items]
Total loans	23,943	26,079	34,655
Multi-family residential | Pass
Financing Receivable, Recorded Investment [Line Items]
Total loans	23,696	25,871
Multi-family residential | Special mention
Financing Receivable, Recorded Investment [Line Items]
Total loans	0	0
Multi-family residential | Substandard
Financing Receivable, Recorded Investment [Line Items]
Total loans	247	208
Multi-family residential | Doubtful
Financing Receivable, Recorded Investment [Line Items]
Total loans	0	0
Consumer
Financing Receivable, Recorded Investment [Line Items]
Total loans	53,206	53,822
Consumer | Pass
Financing Receivable, Recorded Investment [Line Items]
Total loans	52,308	52,648
Consumer | Special mention
Financing Receivable, Recorded Investment [Line Items]
Total loans	440	524
Consumer | Substandard
Financing Receivable, Recorded Investment [Line Items]
Total loans	397	568
Consumer | Doubtful
Financing Receivable, Recorded Investment [Line Items]
Total loans	61	82
Agricultural
Financing Receivable, Recorded Investment [Line Items]
Total loans	21,473	18,901	$ 19,808
Agricultural | Pass
Financing Receivable, Recorded Investment [Line Items]
Total loans	19,802	17,965
Agricultural | Special mention
Financing Receivable, Recorded Investment [Line Items]
Total loans	972	478
Agricultural | Substandard
Financing Receivable, Recorded Investment [Line Items]
Total loans	699	458
Agricultural | Doubtful
Financing Receivable, Recorded Investment [Line Items]
Total loans	$ 0	$ 0

LOANS AND ALLOWANCE FOR LOAN 43

LOANS AND ALLOWANCE FOR LOAN LOSSES - Summary of Payment Status of Loans (Details) - USD ($) $ in Thousands	Mar. 31, 2017	Dec. 31, 2016	Mar. 31, 2016
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Past Due Loans	$ 8,868	$ 11,700
Current Loans	1,244,275	1,233,435
Ending balance	1,253,143	1,245,135	$ 1,142,064
Recorded Investment 90 Days and Accruing	0	0
30 to 59 Days Past Due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Past Due Loans	6,573	7,346
60 to 89 Days Past Due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Past Due Loans	852	1,220
90 Days and Greater Past Due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Past Due Loans	1,443	3,134
Commercial and industrial
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Past Due Loans	671	1,071
Current Loans	205,232	222,926
Ending balance	205,903	223,997	216,929
Recorded Investment 90 Days and Accruing	0	0
Commercial and industrial | 30 to 59 Days Past Due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Past Due Loans	460	941
Commercial and industrial | 60 to 89 Days Past Due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Past Due Loans	181	105
Commercial and industrial | 90 Days and Greater Past Due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Past Due Loans	30	25
Construction and development
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Past Due Loans	60	1,898
Current Loans	152,700	127,468
Ending balance	152,760	129,366	92,831
Recorded Investment 90 Days and Accruing	0	0
Construction and development | 30 to 59 Days Past Due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Past Due Loans	60	73
Construction and development | 60 to 89 Days Past Due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Past Due Loans	0	0
Construction and development | 90 Days and Greater Past Due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Past Due Loans	0	1,825
Commercial real estate
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Past Due Loans	1,402	1,795
Current Loans	371,453	365,861
Ending balance	372,855	367,656	336,999
Recorded Investment 90 Days and Accruing	0	0
Commercial real estate | 30 to 59 Days Past Due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Past Due Loans	1,225	1,629
Commercial real estate | 60 to 89 Days Past Due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Past Due Loans	41	32
Commercial real estate | 90 Days and Greater Past Due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Past Due Loans	136	134
Farmland
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Past Due Loans	114	133
Current Loans	62,016	62,229
Ending balance	62,130	62,362	54,321
Recorded Investment 90 Days and Accruing	0	0
Farmland | 30 to 59 Days Past Due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Past Due Loans	114	100
Farmland | 60 to 89 Days Past Due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Past Due Loans	0	26
Farmland | 90 Days and Greater Past Due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Past Due Loans	0	7
1-4 family residential
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Past Due Loans	5,373	5,568
Current Loans	355,500	357,384
Ending balance	360,873	362,952	334,423
Recorded Investment 90 Days and Accruing	0	0
1-4 family residential | 30 to 59 Days Past Due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Past Due Loans	3,867	3,724
1-4 family residential | 60 to 89 Days Past Due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Past Due Loans	323	803
1-4 family residential | 90 Days and Greater Past Due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Past Due Loans	1,183	1,041
Multi-family residential
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Past Due Loans	247	256
Current Loans	23,696	25,823
Ending balance	23,943	26,079	34,655
Recorded Investment 90 Days and Accruing	0	0
Multi-family residential | 30 to 59 Days Past Due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Past Due Loans	49	207
Multi-family residential | 60 to 89 Days Past Due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Past Due Loans	198	49
Multi-family residential | 90 Days and Greater Past Due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Past Due Loans	0	0
Consumer
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Past Due Loans	785	905
Current Loans	52,031	52,600
Ending balance	52,816	53,505	51,552
Recorded Investment 90 Days and Accruing	0	0
Consumer | 30 to 59 Days Past Due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Past Due Loans	610	613
Consumer | 60 to 89 Days Past Due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Past Due Loans	95	205
Consumer | 90 Days and Greater Past Due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Past Due Loans	80	87
Agricultural
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Past Due Loans	216	74
Current Loans	21,257	18,827
Ending balance	21,473	18,901	19,808
Recorded Investment 90 Days and Accruing	0	0
Agricultural | 30 to 59 Days Past Due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Past Due Loans	188	59
Agricultural | 60 to 89 Days Past Due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Past Due Loans	14	0
Agricultural | 90 Days and Greater Past Due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Past Due Loans	14	15
Overdrafts
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Past Due Loans	0	0
Current Loans	390	317
Ending balance	390	317	$ 546
Recorded Investment 90 Days and Accruing	0	0
Overdrafts | 30 to 59 Days Past Due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Past Due Loans	0	0
Overdrafts | 60 to 89 Days Past Due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Past Due Loans	0	0
Overdrafts | 90 Days and Greater Past Due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Past Due Loans	$ 0	$ 0

LOANS AND ALLOWANCE FOR LOAN 44

LOANS AND ALLOWANCE FOR LOAN LOSSES - Schedule of Nonaccrual Loans (Details) - USD ($) $ in Thousands	Mar. 31, 2017	Dec. 31, 2016
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loans	$ 3,066	$ 4,409
Commercial and industrial
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loans	517	82
Construction and development
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loans	0	1,825
Commercial real estate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loans	136	415
Farmland
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loans	163	176
1-4 family residential
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loans	1,772	1,699
Multi-family residential
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loans	0	5
Consumer
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loans	165	192
Agricultural
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loans	$ 313	$ 15

LOANS AND ALLOWANCE FOR LOAN 45

LOANS AND ALLOWANCE FOR LOAN LOSSES - Troubled Debt Restructuring (Details)	3 Months Ended
	Mar. 31, 2017USD ($)contract	Mar. 31, 2016USD ($)contract	Dec. 31, 2016USD ($)
Financing Receivable, Modifications [Line Items]
Total	$ 372,000		$ 505,000
Specific reserves on TDRs	$ 4,000		4,000
Troubled Debt Restructurings:
Number of Contracts | contract	2	3
Pre-Modification Outstanding Recorded Investment	$ 45,000	$ 23,000
Post-Modification Outstanding Recorded Investment	45,000	23,000
Troubled debt restructuring charge-offs	$ 0	$ 0
Commercial and industrial
Troubled Debt Restructurings:
Number of Contracts | contract	1
Pre-Modification Outstanding Recorded Investment	$ 34,000
Post-Modification Outstanding Recorded Investment	$ 34,000
1-4 family residential
Troubled Debt Restructurings:
Number of Contracts | contract	1
Pre-Modification Outstanding Recorded Investment	$ 11,000
Post-Modification Outstanding Recorded Investment	11,000
Consumer
Troubled Debt Restructurings:
Number of Contracts | contract		3
Pre-Modification Outstanding Recorded Investment		$ 23,000
Post-Modification Outstanding Recorded Investment		$ 23,000
Nonaccrual TDRs
Financing Receivable, Modifications [Line Items]
Total	42,000		90,000
Performing TDRs
Financing Receivable, Modifications [Line Items]
Total	$ 330,000		$ 415,000

LOANS AND ALLOWANCE FOR LOAN 46

LOANS AND ALLOWANCE FOR LOAN LOSSES - Summary of Impaired Loans (Details) - USD ($) $ in Thousands	3 Months Ended	12 Months Ended
	Mar. 31, 2017	Dec. 31, 2016
Recorded Investment [Abstract]
Recorded Investment, With no related allowance recorded	$ 8,481	$ 5,062
Recorded Investment, With related allowance recorded	1,681	1,256
Recorded Investment	10,162	6,318
Unpaid Principal Balance [Abstract]
Unpaid Principal Balance, With no related allowance recorded	8,481	5,062
Unpaid Principal Balance, With related allowance recorded	1,681	1,256
Unpaid Principal Balance	10,162	6,318
Related Allowance [Abstract]
Related Allowance	241	253
Average Recorded Investment [Abstract]
Average Recorded Investment, With no related allowance recorded	8,473	3,695
Average Recorded Investment, With related allowance recorded	1,747	4,118
Average Recorded Investment	10,220	7,813
Interest Income Recognized [Abstract]
Interest Income Recognized, With no related allowance recorded	114	260
Interest Income Recognized, With related allowance recorded	18	57
Interest Income Recognized	132	317
Commercial and industrial
Recorded Investment [Abstract]
Recorded Investment, With no related allowance recorded	373	28
Recorded Investment, With related allowance recorded	546	203
Unpaid Principal Balance [Abstract]
Unpaid Principal Balance, With no related allowance recorded	373	28
Unpaid Principal Balance, With related allowance recorded	546	203
Related Allowance [Abstract]
Related Allowance	129	64
Average Recorded Investment [Abstract]
Average Recorded Investment, With no related allowance recorded	159	809
Average Recorded Investment, With related allowance recorded	624	3,153
Interest Income Recognized [Abstract]
Interest Income Recognized, With no related allowance recorded	5	3
Interest Income Recognized, With related allowance recorded	10	4
Construction and development
Recorded Investment [Abstract]
Recorded Investment, With no related allowance recorded	0	1,825
Unpaid Principal Balance [Abstract]
Unpaid Principal Balance, With no related allowance recorded	0	1,825
Average Recorded Investment [Abstract]
Average Recorded Investment, With no related allowance recorded	1,217	172
Interest Income Recognized [Abstract]
Interest Income Recognized, With no related allowance recorded	0	84
Commercial real estate
Recorded Investment [Abstract]
Recorded Investment, With no related allowance recorded	5,893	1,196
Recorded Investment, With related allowance recorded	518
Unpaid Principal Balance [Abstract]
Unpaid Principal Balance, With no related allowance recorded	5,893	1,196
Unpaid Principal Balance, With related allowance recorded	518
Related Allowance [Abstract]
Related Allowance	31
Average Recorded Investment [Abstract]
Average Recorded Investment, With no related allowance recorded	4,936	871
Average Recorded Investment, With related allowance recorded	251
Interest Income Recognized [Abstract]
Interest Income Recognized, With no related allowance recorded	73	47
Interest Income Recognized, With related allowance recorded	3
Farmland
Recorded Investment [Abstract]
Recorded Investment, With no related allowance recorded	7	89
Recorded Investment, With related allowance recorded	163	169
Unpaid Principal Balance [Abstract]
Unpaid Principal Balance, With no related allowance recorded	7	89
Unpaid Principal Balance, With related allowance recorded	163	169
Related Allowance [Abstract]
Related Allowance	41	47
Average Recorded Investment [Abstract]
Average Recorded Investment, With no related allowance recorded	65	109
Average Recorded Investment, With related allowance recorded	163	169
Interest Income Recognized [Abstract]
Interest Income Recognized, With no related allowance recorded	0	5
Interest Income Recognized, With related allowance recorded	0	1
1-4 family residential
Recorded Investment [Abstract]
Recorded Investment, With no related allowance recorded	1,315	1,799
Recorded Investment, With related allowance recorded	454	789
Unpaid Principal Balance [Abstract]
Unpaid Principal Balance, With no related allowance recorded	1,315	1,799
Unpaid Principal Balance, With related allowance recorded	454	789
Related Allowance [Abstract]
Related Allowance	40	108
Average Recorded Investment [Abstract]
Average Recorded Investment, With no related allowance recorded	1,675	1,575
Average Recorded Investment, With related allowance recorded	609	639
Interest Income Recognized [Abstract]
Interest Income Recognized, With no related allowance recorded	18	106
Interest Income Recognized, With related allowance recorded	5	44
Multi-family residential
Recorded Investment [Abstract]
Recorded Investment, With no related allowance recorded	247	5
Unpaid Principal Balance [Abstract]
Unpaid Principal Balance, With no related allowance recorded	247	5
Average Recorded Investment [Abstract]
Average Recorded Investment, With no related allowance recorded	102	2
Interest Income Recognized [Abstract]
Interest Income Recognized, With no related allowance recorded	4	1
Consumer
Recorded Investment [Abstract]
Recorded Investment, With no related allowance recorded	34	105
Recorded Investment, With related allowance recorded	0	95
Unpaid Principal Balance [Abstract]
Unpaid Principal Balance, With no related allowance recorded	34	105
Unpaid Principal Balance, With related allowance recorded	0	95
Related Allowance [Abstract]
Related Allowance	0	34
Average Recorded Investment [Abstract]
Average Recorded Investment, With no related allowance recorded	105	89
Average Recorded Investment, With related allowance recorded	100	155
Interest Income Recognized [Abstract]
Interest Income Recognized, With no related allowance recorded	1	12
Interest Income Recognized, With related allowance recorded		8
Agricultural
Recorded Investment [Abstract]
Recorded Investment, With no related allowance recorded	612	15
Recorded Investment, With related allowance recorded		0
Unpaid Principal Balance [Abstract]
Unpaid Principal Balance, With no related allowance recorded	612	15
Unpaid Principal Balance, With related allowance recorded		0
Related Allowance [Abstract]
Related Allowance		0
Average Recorded Investment [Abstract]
Average Recorded Investment, With no related allowance recorded	214	68
Average Recorded Investment, With related allowance recorded		2
Interest Income Recognized [Abstract]
Interest Income Recognized, With no related allowance recorded	$ 13	2
Interest Income Recognized, With related allowance recorded		$ 0

SECURITIES SOLD UNDER AGREEME47

SECURITIES SOLD UNDER AGREEMENTS TO REPURCHASE AND OTHER DEBT - Narrative (Details)	Mar. 31, 2017USD ($)debt_instrument	Dec. 31, 2016USD ($)
Line of Credit Facility [Line Items]
Securities sold under agreements to repurchase	$ 12,663,000	$ 10,859,000
Line of Credit | Unsecured Line of Credit
Line of Credit Facility [Line Items]
Number of debt instruments | debt_instrument	1
Maximum borrowing capacity	$ 25,000,000
Outstanding balance	$ 18,929,000
Line of Credit | Unsecured Line of Credit | Prime Rate
Line of Credit Facility [Line Items]
Spread on variable rate	0.50%

SUBORDINATED DEBENTURES - Sche

SUBORDINATED DEBENTURES - Schedule of Subordinated Debentures (Details) - USD ($) $ in Thousands	Mar. 31, 2017	Dec. 31, 2016
Debt Instrument [Line Items]
Debentures	$ 19,310	$ 19,310
Debentures II
Debt Instrument [Line Items]
Debentures	3,093	3,093
Debentures III
Debt Instrument [Line Items]
Debentures	2,062	2,062
DCB Debentures I
Debt Instrument [Line Items]
Debentures	5,155	5,155
Other Debentures
Debt Instrument [Line Items]
Debentures	$ 9,000	$ 9,000

SUBORDINATED DEBENTURES - Narra

SUBORDINATED DEBENTURES - Narrative (Details)	1 Months Ended	3 Months Ended	12 Months Ended
	May 31, 2017USD ($)	Mar. 31, 2017USD ($)trust$ / shares	Dec. 31, 2016	Dec. 31, 2015USD ($)	Jul. 31, 2015USD ($)
Subsequent Event
Debt Instrument [Line Items]
Repayment of subordinated debentures	$ 5,000,000
Trust Preferred Securities Subject to Mandatory Redemption
Debt Instrument [Line Items]
Number of trusts | trust		3
Liquidation value per share (in USD per share) | $ / shares		$ 1,000
Subordinated Debentures
Debt Instrument [Line Items]
Debenture term		30 years
Subordinated Debentures | Debentures II
Debt Instrument [Line Items]
Debenture issued		$ 3,093,000
Subordinated Debentures | Debentures II | 3 Month LIBOR
Debt Instrument [Line Items]
Spread on variable rate		3.35%
Subordinated Debentures | Debentures II | Minimum
Debt Instrument [Line Items]
Notice period required for redemption of debentures		30 days
Subordinated Debentures | Debentures II | Maximum
Debt Instrument [Line Items]
Notice period required for redemption of debentures		60 days
Redemption price of debentures as a percentage of principal		100.00%
Subordinated Debentures | Debentures III
Debt Instrument [Line Items]
Debenture issued		$ 2,062,000
Subordinated Debentures | Debentures III | 3 Month LIBOR
Debt Instrument [Line Items]
Spread on variable rate		1.67%	1.67%
Subordinated Debentures | Debentures III | Minimum
Debt Instrument [Line Items]
Notice period required for redemption of debentures		30 days
Subordinated Debentures | Debentures III | Maximum
Debt Instrument [Line Items]
Notice period required for redemption of debentures		60 days
Redemption price of debentures as a percentage of principal		100.00%
Subordinated Debentures | DCB Debentures I
Debt Instrument [Line Items]
Debenture issued		$ 5,155,000
Subordinated Debentures | DCB Debentures I | 3 Month LIBOR
Debt Instrument [Line Items]
Spread on variable rate		1.80%
Subordinated Debentures | DCB Debentures I | Minimum
Debt Instrument [Line Items]
Notice period required for redemption of debentures		30 days
Subordinated Debentures | DCB Debentures I | Maximum
Debt Instrument [Line Items]
Notice period required for redemption of debentures		60 days
Redemption price of debentures as a percentage of principal		100.00%
Subordinated Debentures | Other Debentures Issued in July 2015
Debt Instrument [Line Items]
Notice period required for redemption of debentures		30 days
Redemption price of debentures as a percentage of principal		100.00%
Debenture issued					$ 4,000,000
Debenture issued, par value per instrument issued					$ 500,000
Subordinated Debentures | Other Debentures Issued in July 2015 | Minimum
Debt Instrument [Line Items]
Stated interest rate					2.50%
Subordinated Debentures | Other Debentures Issued in July 2015 | Maximum
Debt Instrument [Line Items]
Stated interest rate					4.00%
Subordinated Debentures | Other Debentures Issued in December 2015
Debt Instrument [Line Items]
Notice period required for redemption of debentures		30 days
Redemption price of debentures as a percentage of principal		100.00%
Debenture issued				$ 5,000,000
Debenture issued, par value per instrument issued				$ 500,000
Subordinated Debentures | Other Debentures Issued in December 2015 | Minimum
Debt Instrument [Line Items]
Stated interest rate				3.00%
Subordinated Debentures | Other Debentures Issued in December 2015 | Maximum
Debt Instrument [Line Items]
Stated interest rate				5.00%
Directors and Related Parties | Subordinated Debentures | Other Debentures Issued in July 2015
Debt Instrument [Line Items]
Debenture issued					$ 3,000,000
Directors and Related Parties | Subordinated Debentures | Other Debentures Issued in December 2015
Debt Instrument [Line Items]
Debenture issued				$ 2,500,000

SUBORDINATED DEBENTURES - Sched

SUBORDINATED DEBENTURES - Schedule of Trusts (Details) $ in Thousands	Mar. 31, 2017USD ($)shares
Trust II
Financial Instruments Subject to Mandatory Redemption by Settlement Terms [Line Items]
Common securities liquidation value	$ 93
Trust III
Financial Instruments Subject to Mandatory Redemption by Settlement Terms [Line Items]
Common securities liquidation value	62
DCB Trust I
Financial Instruments Subject to Mandatory Redemption by Settlement Terms [Line Items]
Common securities liquidation value	$ 155
Trust Preferred Securities Subject to Mandatory Redemption | Trust II
Financial Instruments Subject to Mandatory Redemption by Settlement Terms [Line Items]
Number of shares (in shares) | shares	3,000,000
Original liquidation value	$ 3,000
Trust Preferred Securities Subject to Mandatory Redemption | Trust III
Financial Instruments Subject to Mandatory Redemption by Settlement Terms [Line Items]
Number of shares (in shares) | shares	2,000,000
Original liquidation value	$ 2,000
Trust Preferred Securities Subject to Mandatory Redemption | DCB Trust I
Financial Instruments Subject to Mandatory Redemption by Settlement Terms [Line Items]
Number of shares (in shares) | shares	5,000,000
Original liquidation value	$ 5,000

SUBORDINATED DEBENTURES - Sch51

SUBORDINATED DEBENTURES - Schedule of Terms of Subordinated Debentures (Details) - Subordinated Debentures $ in Thousands	Mar. 31, 2017USD ($)
Debentures II
Debt Instrument [Line Items]
Original amount	$ 3,093
Debentures III
Debt Instrument [Line Items]
Original amount	2,062
DCB Debentures I
Debt Instrument [Line Items]
Original amount	$ 5,155

STOCK OPTIONS - Narrative (Deta

STOCK OPTIONS - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation cost, nonvested options	$ 995
Option
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Contractual term	10 years
Unrecognized compensation cost, nonvested options, period for recognition	4 years 7 months 17 days
Option | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period	5 years
Option | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period	10 years
2015 Equity Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares permitted for grant (in shares)	1,000,000
2015 Equity Incentive Plan | Option
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation expense	$ 60	$ 39

STOCK OPTIONS - Schedule of Opt

STOCK OPTIONS - Schedule of Option Activity (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		12 Months Ended
	Mar. 31, 2017	Mar. 31, 2016	Dec. 31, 2016	Dec. 31, 2015
Number of Shares
Beginning balance (in shares)	340,377	314,391	314,391
Granted (in shares)	9,000	21,000
Exercised (in shares)	(2,010)
Forfeited (in shares)	(1,000)	(10,400)
Ending balance (in shares)	346,367	324,991	340,377	314,391
Weighted-Average Exercise Price
Beginning balance (in USD per share)	$ 23.43	$ 23.28	$ 23.28
Granted (in USD per share)	26	23
Exercised (in USD per share)	11.94
Forfeited (in USD per share)	24	23.23
Ending balance (in USD per share)	$ 23.56	$ 23.27	$ 23.43	$ 23.28
Weighted-Average Remaining Contractual Life in Years
Outstanding	7 years 2 months 9 days	7 years 10 months 10 days	7 years 4 months 2 days	8 years
Granted	9 years 11 months 16 days	8 years 9 months 15 days
Exercised	3 years 29 days
Forfeited	5 years 6 months 18 days	7 years 8 months 27 days
Aggregate Intrinsic Value
Outstanding	$ 844	$ 238	$ 194	$ 225
Granted	0	21
Intrinsic value of options exercised	28
Forfeited	$ 2	$ 8
Exercisable
Outstanding (in shares)	92,667	47,191
Weighted-average exercise price (in USD per share)	$ 22.91	$ 20.83
Weighted-average remaining contractual life in years	6 years 5 months 16 days	6 years 6 months 4 days
Aggregate intrinsic value	$ 287	$ 149

STOCK OPTIONS - Schedule of Non

STOCK OPTIONS - Schedule of Nonvested Option Activity (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		12 Months Ended
	Mar. 31, 2017	Mar. 31, 2016	Dec. 31, 2016	Dec. 31, 2015
Number of Shares
Beginning balance (in shares)	250,700	267,200	267,200
Granted (in shares)	9,000	21,000
Vested (in shares)	(6,000)	(10,400)
Ending balance (in shares)	253,700	277,800	250,700	267,200
Weighted-Average Exercise Price
Beginning balance (in USD per share)	$ 23.73	$ 23.72	$ 23.72
Granted (in USD per share)	26	23
Vested (in USD per share)	23.90	23.23
Ending balance (in USD per share)	$ 23.80	$ 23.68	$ 23.73	$ 23.72
Weighted-Average Remaining Contractual Life in Years
Outstanding	7 years 5 months 16 days	8 years 1 month 2 days	7 years 7 months 24 days	8 years 2 months 19 days
Granted	9 years 11 months 16 days	8 years 9 months 15 days
Vested	9 years 1 month 24 days	7 years 5 months 19 days
Aggregate Intrinsic Value
Outstanding	$ 557	$ 89	$ 69	$ 0
Granted	0	21
Vested	$ 13	$ 8

STOCK OPTIONS - Information Rel

STOCK OPTIONS - Information Related to Plan (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Intrinsic value of options exercised	$ 28
Cash received from options exercised	24	$ 0
Tax benefit realized from options exercised	$ 0
Weighted average fair value of options granted (in USD per share)	$ 4.30

EMPLOYEE BENEFITS - Narrative

EMPLOYEE BENEFITS - Narrative (Details) - USD ($)	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016	Dec. 31, 2016
Retirement Benefits [Abstract]
Employee stock ownership plan, maximum employer contribution as a percentage of participant's qualified compensation	5.00%
Employee stock ownership plan, total contributions accrued or paid	$ 226,000	$ 234,000
Employee stock ownership plan, fair value of shares subject to repurchase obligation	$ 34,300,000		$ 31,661,000
Employee stock ownership plan, shares held under plan (in shares)	1,319,225		1,319,225
Employee stock ownership plan, unallocated shares (in shares)	50,000		50,000
Defined Benefit Plan Disclosure [Line Items]
Cash surrender value of life insurance	$ 17,922,000		$ 17,804,000
Bonus expense	$ 581,000	499,000
Unfunded Plan | Nonqualified Plan | Supplemental Retirement Plan | Supplemental Employee Retirement Plan
Defined Benefit Plan Disclosure [Line Items]
Salary period used for determining benefit	5 years
Defined benefit plan expense	$ 0	0
Recorded obligation, defined benefit plan	0		5,000
Unfunded Plan | Nonqualified Plan | Executive Incentive Retirement Plan | Postretirement Life Insurance
Defined Benefit Plan Disclosure [Line Items]
Cash surrender value of life insurance	17,922,000		17,804,000
Plan cost	256,000	$ 196,000
Plan obligation	$ 2,251,000		$ 2,002,000

INCOME TAXES - Schedule of Inc

INCOME TAXES - Schedule of Income Tax Expense (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Income Tax Disclosure [Abstract]
Income tax expense for the period	$ 1,312	$ 1,090
Effective tax rate	27.19%	28.93%

INCOME TAXES - Narrative (Detai

INCOME TAXES - Narrative (Details)	3 Months Ended
	Mar. 31, 2017
Income Tax Disclosure [Abstract]
Statutory federal rate	35.00%

DERIVATIVE FINANCIAL INSTRUME59

DERIVATIVE FINANCIAL INSTRUMENTS - Narrative (Details) - USD ($)	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016	Dec. 31, 2016
Derivative [Line Items]
Interest expense	$ 2,895,000	$ 2,666,000
Unrealized loss to be reclassified as a reduction of interest expense	0
Ineffectiveness included in net income	0	0
Designated as Hedging Instrument | Cash Flow Hedging | Interest Rate Swap
Derivative [Line Items]
Notional Amount	5,000,000		$ 5,000,000
Interest expense	$ 207,000	$ 222,000

DERIVATIVE FINANCIAL INSTRUME60

DERIVATIVE FINANCIAL INSTRUMENTS - Schedule of Interest Rate Swaps (Details) - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2017	Dec. 31, 2016
LIBOR | Subordinated Debentures | Debentures III
Derivative [Line Items]
Receive Rate	1.67%	1.67%
LIBOR | Subordinated Debentures | Debentures II
Derivative [Line Items]
Receive Rate	3.35%
Designated as Hedging Instrument | LIBOR | Debentures II
Derivative [Line Items]
Receive Rate	3.35%	3.35%
Designated as Hedging Instrument | Interest Rate Swap, 3 month LIBOR plus 1.67%
Derivative [Line Items]
Unrealized Losses	$ 329,000	$ 342,000
Designated as Hedging Instrument | Interest Rate Swap, 3 month LIBOR plus 3.35%
Derivative [Line Items]
Unrealized Losses	331,000	353,000
Designated as Hedging Instrument | Cash Flow Hedging | Interest Rate Swap, 3 month LIBOR plus 1.67%
Derivative [Line Items]
Notional Amount	$ 2,000,000	$ 2,000,000
Pay Rate	5.979%	5.979%
Maturity in Years	9 years 4 days	9 years 3 months
Designated as Hedging Instrument | Cash Flow Hedging | Interest Rate Swap, 3 month LIBOR plus 3.35%
Derivative [Line Items]
Notional Amount	$ 3,000,000	$ 3,000,000
Pay Rate	7.505%	7.505%
Maturity in Years	5 years 7 months 2 days	5 years 9 months 29 days

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES - Schedule of Commitments and Letters of Credit (Details) - USD ($) $ in Thousands	Mar. 31, 2017	Dec. 31, 2016
Commitments to extend credit
Other Commitments [Line Items]
Off-balance sheet liability	$ 350,323	$ 297,607
Letters of credit
Other Commitments [Line Items]
Off-balance sheet liability	$ 9,113	$ 8,879

COMMITMENTS AND CONTINGENCIES -

COMMITMENTS AND CONTINGENCIES - Narrative (Details) - USD ($)	Mar. 31, 2017	Dec. 31, 2016
Other Commitments [Line Items]
FHLB letters of credit	$ 77,000,000
Letters of credit
Other Commitments [Line Items]
Potential guarantee obligation	$ 0	$ 0

REGULATORY MATTERS - Compariso

REGULATORY MATTERS - Comparison of the Company's and Bank's Actual Capital Amounts and Ratios to Required Capital Amounts and Ratios (Details) - USD ($) $ in Thousands	Mar. 31, 2017	Dec. 31, 2016
Total capital to risk-weighted assets:
Actual, Amount	$ 152,967	$ 149,468
Actual, Ratio	10.84%	10.86%
Minimum Required for Capital Adequacy Purposes, Amount	$ 112,877	$ 110,083
Minimum Required for Capital Adequacy Purposes, Ratio	8.00%	8.00%
Tier 1 capital to risk-weighted assets:
Actual, Amount	$ 141,039	$ 137,984
Actual, Ratio	10.00%	10.03%
Minimum Required for Capital Adequacy Purposes, Amount	$ 84,658	$ 82,562
Minimum Required for Capital Adequacy Purposes, Ratio	6.00%	6.00%
Tier 1 capital to average assets:
Actual, Amount	$ 141,039	$ 137,984
Actual, Ratio	7.66%	7.71%
Minimum Required for Capital Adequacy Purposes, Amount	$ 73,640	$ 71,560
Minimum Required for Capital Adequacy Purposes, Ratio	4.00%	4.00%
Common equity tier 1 risk-based capital:
Actual, Amount	$ 130,729	$ 127,674
Actual, Ratio	9.27%	9.28%
Minimum Required for Capital Adequacy Purposes, Amount	$ 63,494	$ 61,922
Minimum Required for Capital Adequacy Purposes, Ratio	4.50%	4.50%
Subordinated Debentures | Subordinated Debentures II, Subordinated Debentures III, and DCB Debentures I
Common equity tier 1 risk-based capital:
Debenture issued	$ 10,310
Bank
Total capital to risk-weighted assets:
Actual, Amount	$ 177,589	$ 173,528
Actual, Ratio	12.60%	12.63%
Minimum Required for Capital Adequacy Purposes, Amount	$ 112,778	$ 109,947
Minimum Required for Capital Adequacy Purposes, Ratio	8.00%	8.00%
To Be Well Capitalized Under Prompt Corrective Action Provisions, Ratio	$ 140,973	$ 137,434
To Be Well Capitalized Under Prompt Corrective Action Provisions, Amount	10.00%	10.00%
Tier 1 capital to risk-weighted assets:
Actual, Amount	$ 165,661	$ 162,044
Actual, Ratio	11.75%	11.79%
Minimum Required for Capital Adequacy Purposes, Amount	$ 84,584	$ 82,460
Minimum Required for Capital Adequacy Purposes, Ratio	6.00%	6.00%
To Be Well Capitalized Under Prompt Correct Action Provisions, Amount	$ 112,778	$ 109,947
To Be Well Capitalized Under Prompt Correct Action Provisions, Ratio	8.00%	8.00%
Tier 1 capital to average assets:
Actual, Amount	$ 165,661	$ 162,044
Actual, Ratio	9.01%	9.06%
Minimum Required for Capital Adequacy Purposes, Amount	$ 73,572	$ 71,505
Minimum Required for Capital Adequacy Purposes, Ratio	4.00%	4.00%
To Be Well Capitalized Under Prompt Corrective Action Provisions, Amount	$ 91,965	$ 89,381
To Be Well Capitalized Under Prompt Corrective Action Provisions, Ratio	5.00%	5.00%
Common equity tier 1 risk-based capital:
Actual, Amount	$ 165,661	$ 162,044
Actual, Ratio	11.75%	11.79%
Minimum Required for Capital Adequacy Purposes, Amount	$ 63,438	$ 61,845
Minimum Required for Capital Adequacy Purposes, Ratio	4.50%	4.50%
To Be Well Capitalized Under Prompt Corrective Action Provisions, Amount	$ 91,632	$ 89,332
To Be Well Capitalized Under Prompt Corrective Action Provisions, Ratio	6.50%	6.50%

FAIR VALUE - Schedule of Financ

FAIR VALUE - Schedule of Financial Assets (Liabilities) Measured at Fair Value (Details) - USD ($) $ in Thousands	Mar. 31, 2017	Dec. 31, 2016
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Securities available for sale	$ 214,463	$ 156,925
Mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Securities available for sale	79,545	59,690
Collateralized mortgage obligations
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Securities available for sale	102,467	65,133
Municipal securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Securities available for sale	7,278	7,219
Corporate bonds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Securities available for sale	25,173	24,883
Assets (liabilities) at fair value on a recurring basis
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative instruments	(661)	(695)
Assets (liabilities) at fair value on a recurring basis | Mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Securities available for sale	79,545	59,690
Assets (liabilities) at fair value on a recurring basis | Collateralized mortgage obligations
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Securities available for sale	102,467	65,133
Assets (liabilities) at fair value on a recurring basis | Municipal securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Securities available for sale	7,278
Assets (liabilities) at fair value on a recurring basis | Corporate bonds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Securities available for sale	25,173	24,883
Assets (liabilities) at fair value on a recurring basis | U.S. treasury securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Securities available for sale		0
Assets (liabilities) at fair value on a recurring basis | Quoted Prices in Active Markets for Identical Assets (Level 1)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative instruments	0	0
Assets (liabilities) at fair value on a recurring basis | Quoted Prices in Active Markets for Identical Assets (Level 1) | Mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Securities available for sale	0	0
Assets (liabilities) at fair value on a recurring basis | Quoted Prices in Active Markets for Identical Assets (Level 1) | Collateralized mortgage obligations
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Securities available for sale	0	0
Assets (liabilities) at fair value on a recurring basis | Quoted Prices in Active Markets for Identical Assets (Level 1) | Municipal securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Securities available for sale	0
Assets (liabilities) at fair value on a recurring basis | Quoted Prices in Active Markets for Identical Assets (Level 1) | Corporate bonds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Securities available for sale	0	0
Assets (liabilities) at fair value on a recurring basis | Quoted Prices in Active Markets for Identical Assets (Level 1) | U.S. treasury securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Securities available for sale		0
Assets (liabilities) at fair value on a recurring basis | Significant Other Observable Inputs (Level 2)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative instruments	(661)	(695)
Assets (liabilities) at fair value on a recurring basis | Significant Other Observable Inputs (Level 2) | Mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Securities available for sale	79,545	59,690
Assets (liabilities) at fair value on a recurring basis | Significant Other Observable Inputs (Level 2) | Collateralized mortgage obligations
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Securities available for sale	102,467	65,133
Assets (liabilities) at fair value on a recurring basis | Significant Other Observable Inputs (Level 2) | Municipal securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Securities available for sale	7,278
Assets (liabilities) at fair value on a recurring basis | Significant Other Observable Inputs (Level 2) | Corporate bonds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Securities available for sale	25,173	24,883
Assets (liabilities) at fair value on a recurring basis | Significant Other Observable Inputs (Level 2) | U.S. treasury securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Securities available for sale		0
Assets (liabilities) at fair value on a recurring basis | Significant Other Unobservable Inputs (Level 3)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative instruments	0	0
Assets (liabilities) at fair value on a recurring basis | Significant Other Unobservable Inputs (Level 3) | Mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Securities available for sale	0	0
Assets (liabilities) at fair value on a recurring basis | Significant Other Unobservable Inputs (Level 3) | Collateralized mortgage obligations
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Securities available for sale	0	0
Assets (liabilities) at fair value on a recurring basis | Significant Other Unobservable Inputs (Level 3) | Municipal securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Securities available for sale	0
Assets (liabilities) at fair value on a recurring basis | Significant Other Unobservable Inputs (Level 3) | Corporate bonds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Securities available for sale	0	0
Assets (liabilities) at fair value on a recurring basis | Significant Other Unobservable Inputs (Level 3) | U.S. treasury securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Securities available for sale		0
Assets (liabilities) at fair value on a nonrecurring basis
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Impaired loans	9,921	6,065
Other real estate owned	1,637	1,692
Assets (liabilities) at fair value on a nonrecurring basis | Quoted Prices in Active Markets for Identical Assets (Level 1)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Impaired loans	0	0
Other real estate owned	0	0
Assets (liabilities) at fair value on a nonrecurring basis | Significant Other Observable Inputs (Level 2)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Impaired loans	0	0
Other real estate owned	0	0
Assets (liabilities) at fair value on a nonrecurring basis | Significant Other Unobservable Inputs (Level 3)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Impaired loans	9,921	6,065
Other real estate owned	$ 1,637	$ 1,692

FAIR VALUE - Fair Value of Fore

FAIR VALUE - Fair Value of Foreclosed Assets (Details) - USD ($) $ in Thousands	Mar. 31, 2017	Dec. 31, 2016	Mar. 31, 2016
Carrying Value | Foreclosed assets remeasured at initial recognition
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Foreclosed assets	$ 87	$ 78	$ 134
Carrying Value | Foreclosed assets remeasured subsequent to initial recognition
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Foreclosed assets	0	170	0
Charge-offs | Foreclosed assets remeasured at initial recognition
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Foreclosed assets	(78)	(11)	(14)
Charge-offs | Foreclosed assets remeasured subsequent to initial recognition
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Foreclosed assets	0	(69)	0
Fair Value | Foreclosed assets remeasured at initial recognition
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Foreclosed assets	9	67	120
Fair Value | Foreclosed assets remeasured subsequent to initial recognition
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Foreclosed assets	$ 0	$ 101	$ 0

FAIR VALUE - Schedule of Quanti

FAIR VALUE - Schedule of Quantitative Information About Nonrecurring Level 3 Fair Value Measurements (Details) - USD ($) $ in Thousands	3 Months Ended		12 Months Ended
	Mar. 31, 2017	Mar. 31, 2016	Dec. 31, 2016
Impaired loans | Fair value of collateral - sales comparison approach | Minimum
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Discount rate	10.00%	10.00%
Impaired loans | Fair value of collateral - sales comparison approach | Maximum
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Discount rate	20.00%	20.00%
Impaired loans | Fair value of collateral - sales comparison approach | Weighted Average
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Discount rate	16.00%	16.00%
Real estate equipment | Fair value of collateral - sales comparison approach | Minimum
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Discount rate	10.00%		40.00%
Real estate equipment | Fair value of collateral - sales comparison approach | Maximum
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Discount rate	20.00%		50.00%
Real estate equipment | Fair value of collateral - sales comparison approach | Weighted Average
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Discount rate	14.00%		42.00%
Other real estate owned | Appraisal value of collateral | Minimum
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Discount rate	10.00%	10.00%
Other real estate owned | Appraisal value of collateral | Maximum
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Discount rate	20.00%	20.00%
Other real estate owned | Appraisal value of collateral | Weighted Average
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Discount rate	16.00%	16.00%
Assets (liabilities) at fair value on a nonrecurring basis | Significant Other Unobservable Inputs (Level 3) | Impaired loans | Fair value of collateral - sales comparison approach
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair Value	$ 9,921		$ 6,065
Assets (liabilities) at fair value on a nonrecurring basis | Significant Other Unobservable Inputs (Level 3) | Other real estate owned | Appraisal value of collateral
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair Value	$ 1,637		$ 1,692

FAIR VALUE - Schedule of Carryi

FAIR VALUE - Schedule of Carrying Amounts and Estimated Fair Value of Assets And Liabilities (Details) - USD ($) $ in Thousands	Mar. 31, 2017	Dec. 31, 2016
Financial assets:
Marketable securities held to maturity	$ 184,412	$ 186,155
Carrying Amount
Financial assets:
Cash, due from banks, federal funds sold and interest-bearing deposits	143,757	127,543
Marketable securities held to maturity	185,837	189,371
Loans, net	1,241,215	1,233,651
Accrued interest receivable	6,304	7,419
Nonmarketable equity securities	7,285	10,500
Cash surrender value of life insurance	17,922	17,804
Financial liabilities:
Deposits	1,671,171	1,576,791
Securities sold under repurchase agreements	12,663	10,859
Accrued interest payable	1,010	889
Other debt	18,929	18,286
Federal Home Loan Bank advances	25,165	55,170
Subordinated debentures	19,310	19,310
Fair Value
Financial assets:
Cash, due from banks, federal funds sold and interest-bearing deposits	143,757	127,543
Marketable securities held to maturity	184,412	186,155
Loans, net	1,246,011	1,235,306
Accrued interest receivable	6,304	7,419
Nonmarketable equity securities	7,285	10,500
Cash surrender value of life insurance	17,922	17,804
Financial liabilities:
Deposits	1,671,827	1,577,490
Securities sold under repurchase agreements	12,663	10,859
Accrued interest payable	1,010	889
Other debt	18,929	18,286
Federal Home Loan Bank advances	25,163	55,160
Subordinated debentures	16,852	16,809
Fair Value | Level 1 Inputs
Financial assets:
Cash, due from banks, federal funds sold and interest-bearing deposits	115,751	100,205
Marketable securities held to maturity	0	0
Loans, net	0	0
Accrued interest receivable	0	0
Nonmarketable equity securities	0	0
Cash surrender value of life insurance	0	0
Financial liabilities:
Deposits	1,335,456	1,234,875
Securities sold under repurchase agreements	0	0
Accrued interest payable	0	0
Other debt	0	0
Federal Home Loan Bank advances	0	0
Subordinated debentures	0	0
Fair Value | Level 2 Inputs
Financial assets:
Cash, due from banks, federal funds sold and interest-bearing deposits	28,006	27,338
Marketable securities held to maturity	184,412	186,155
Loans, net	0	0
Accrued interest receivable	6,304	7,419
Nonmarketable equity securities	7,285	10,500
Cash surrender value of life insurance	17,922	17,804
Financial liabilities:
Deposits	336,371	342,615
Securities sold under repurchase agreements	12,663	10,859
Accrued interest payable	1,010	889
Other debt	18,929	18,286
Federal Home Loan Bank advances	25,163	55,160
Subordinated debentures	16,852	16,809
Fair Value | Level 3 Inputs
Financial assets:
Cash, due from banks, federal funds sold and interest-bearing deposits	0	0
Marketable securities held to maturity	0	0
Loans, net	1,246,011	1,235,306
Accrued interest receivable	0	0
Nonmarketable equity securities	0	0
Cash surrender value of life insurance	0	0
Financial liabilities:
Deposits	0	0
Securities sold under repurchase agreements	0	0
Accrued interest payable	0	0
Other debt	0	0
Federal Home Loan Bank advances	0	0
Subordinated debentures	$ 0	$ 0

EARNINGS PER SHARE - Schedule

EARNINGS PER SHARE - Schedule of Basic and Diluted Earnings Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Numerator:
Net earnings (basic)	$ 3,516	$ 2,677
Net earnings (diluted)	$ 3,516	$ 2,677
Denominator:
Weighted-average shares outstanding (basic) (in shares)	8,751,945	8,968,052
Effect of dilutive securities:
Common stock equivalent shares from stock options (in shares)	32,465	9,914
Weighted-average shares outstanding (diluted) (in shares)	8,784,410	8,977,966
Net earnings per share
Basic (in USD per share)	$ 0.40	$ 0.30
Diluted (in USD per share)	$ 0.40	$ 0.30